{
  "meta": {
    "title": "00316_Late_Night_Pyqs_Neetpg_-_Final_35",
    "url": "https://brainandscalpel.vercel.app/00316-late-night-pyqs-neetpg-final-35-a5e7fe7c.html",
    "scrapedAt": "2025-11-29T17:28:57.530Z"
  },
  "questions": [
    {
      "id": 84316,
      "choices": [
        {
          "id": 335840,
          "text": "<p>Subthalamus</p>"
        },
        {
          "id": 335841,
          "text": "<p>Globus pallidus</p>"
        },
        {
          "id": 335842,
          "text": "<p>Substantia nigra</p>"
        },
        {
          "id": 335843,
          "text": "<p>Striatum</p>"
        }
      ],
      "text": "<p>What part of the brain is primarily damaged in cases of chorea? (NEET PG 2016)</p>",
      "unique_key": "Q9679851",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><strong>Ans. D) Striatum</strong></p><p>&nbsp;</p><p>Chorea is characterized by involuntary, rapid, irregular, and purposeless movements that flow from one body part to another. The primary pathological changes in chorea involve the striatum (caudate nucleus and putamen). In Huntington's disease, the most well-known cause of chorea, there is selective degeneration of medium spiny neurons in the striatum, with progressive atrophy of the caudate nucleus and putamen visible on neuroimaging. This striatal degeneration disrupts the normal inhibitory output to the globus pallidus, ultimately leading to disinhibition of the thalamus and excessive movement manifestations.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A. Subthalamus:</strong> While the subthalamic nucleus plays an important role in the basal ganglia circuitry and movement control, it is not the primary site of pathology in chorea. Damage to the subthalamic nucleus typically results in hemiballismus, which involves more violent, flinging movements than chorea.</p><p>&nbsp;</p><p><strong>Option B. Globus pallidus:</strong> The globus pallidus is affected secondarily in chorea due to altered inputs from the diseased striatum. Primary globus pallidus lesions more commonly result in parkinsonian features or dystonia rather than chorea.</p><p>&nbsp;</p><p><strong>Option C. Substantia nigra:</strong> The substantia nigra is the primary site of degeneration in Parkinson's disease, leading to dopamine deficiency and hypokinetic movement disorders. It is not the primary site of pathology in choretic disorders.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Chorea primarily results from pathology in the striatum (caudate nucleus and putamen), which disrupts the normal basal ganglia circuitry and leads to disinhibition of thalamic nuclei, resulting in the characteristic random, flowing involuntary movements.</p>",
      "correct_choice_id": 335843,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76191,
      "choices": [
        {
          "id": 303637,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Case control study</span></p>"
        },
        {
          "id": 303638,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Prospective study</span></p>"
        },
        {
          "id": 303639,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Cross sectional study</span></p>"
        },
        {
          "id": 303640,
          "text": "<p><span style=\"font-size:16px;\">Ecological study</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a study based in Delhi from 2012-2022, doctors followed up 100 people who did exercise on a daily basis for a year. Later, they checked who all had developed coronary heart disease among them. This is a type of: (FMGE JAN 2025)</span></p>",
      "unique_key": "Q9292484",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337728,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. B) Prospective study</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">This is a prospective or cohort study because:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The exposure (<strong>exercise</strong>) was identified first</span></li><li><span style=\"font-size:16px;\">The subjects were followed up over time (<strong>10 years from 2012 to 2022</strong>)</span></li><li><span style=\"font-size:16px;\">The outcome <strong>(coronary heart disease)</strong> was measured later</span></li><li><span style=\"font-size:16px;\">The direction of the study is forward in time <strong>(from exposure to outcome)</strong></span></li><li><span style=\"font-size:16px;\">The study follows a group of similar individuals (cohort) over time</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option A. Case control study:&nbsp;</strong>Incorrect because case control studies are retrospective, starting with the outcome (disease) and looking back at exposures. Here, the study started with exposure and looked forward.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Cross sectional study:&nbsp;</strong>Incorrect because cross sectional studies measure exposure and outcome at the same point in time. This study involved follow-up over 10 years.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Ecological study:&nbsp;</strong>Incorrect because ecological studies analyze population-level data rather than individual data. This study followed individual subjects.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">A study that starts with exposure, follows subjects over time, and measures outcomes later is a prospective/cohort study.</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_dqWvmmv.png\" width=\"975\" height=\"298\"></span></p>",
      "correct_choice_id": 303638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 76197,
      "choices": [
        {
          "id": 303661,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Network analysis and machinery installed</span></p>"
        },
        {
          "id": 303662,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Equipment ordered and staff training</span></p>"
        },
        {
          "id": 303663,
          "text": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">Work sampling and machinery installed</span></p>"
        },
        {
          "id": 303664,
          "text": "<p><span style=\"font-size:16px;\">Work sampling and staff training</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Study the management technique given in the diagram. Identify the technique and find out the critical path. (FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_eyVjeQG.png\" width=\"1449\" height=\"550\"></span></p>",
      "unique_key": "Q5877291",
      "question_audio": null,
      "question_video": null,
      "map_id": 29336695,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Ans. A) Network analysis and machinery installed</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">The diagram shows a network analysis technique that includes PERT (Program Evaluation and Review Technique) and CPM (Critical Path Method). When analyzing the two possible paths:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Path 1:</strong> 4 + 2 + 1 + 1 = 8 months total duration</span></li><li><span style=\"font-size:16px;\"><strong>Path 2:</strong> 2 + 10 + 1 = 13 months total duration The critical path is the longer duration path (13 months), where equipment installation takes the longest time (10 months), making it the most critical component.</span></li></ul><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option B. Equipment ordered and staff training:&nbsp;</strong>Incorrect as these are components but not the critical path which has the longest duration&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option C. Work sampling and machinery installed:&nbsp;</strong>Incorrect as this is not a work sampling technique, which is used for observing work activities&nbsp;</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Option D. Work sampling and staff training:&nbsp;</strong>Incorrect<strong>&nbsp;</strong>as the diagram shows network analysis, not work sampling</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p style=\"margin-left:0cm;\">&nbsp;</p><p style=\"margin-left:0cm;\"><span style=\"font-size:16px;\">&nbsp;Network analysis consists of two components:</span></p><p style=\"margin-left:0cm;\">&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>PERT (Program Evaluation and Review Technique)</strong> - Shows sequence of activities</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_wXKhRvw.png\" width=\"986\" height=\"274\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CPM (Critical Path Method)&nbsp;</strong>- Identifies the longest duration path in the network</span></p>",
      "correct_choice_id": 303661,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11251,
      "choices": [
        {
          "id": 44970,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism</span></span></p>"
        },
        {
          "id": 44971,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothermia</span></span></p>"
        },
        {
          "id": 44972,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia</span></span></p>"
        },
        {
          "id": 44973,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypokalemia</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osborn waves in ECG are seen in: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q3955187",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341445,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Hypothermia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Osborn waves, also known as J-waves, are characteristic findings on an ECG that are typically associated with hypothermia. These waves appear as a positive deflection at the J point (the junction between the end of the QRS complex and the beginning of the ST segment) and are most evident in moderate to severe cases of hypothermia. The appearance of Osborn waves is thought to be caused by a disparity in the action potential durations between the epicardial and endocardial surfaces of the heart during ventricular repolarization.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypothyroidism:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition does not typically cause Osborn waves. Instead, hypothyroidism can lead to other ECG changes such as bradycardia, low voltage, and possibly prolonged QT interval.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hypocalcemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This typically leads to a prolonged QT interval but does not cause Osborn waves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hypokalemia:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While hypokalemia can cause significant ECG changes, including U waves, flattened T waves, and ST depression, it is not associated with Osborn waves.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture3_XRys82B.jpg\" style=\"height:288px; width:400px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">J-wave or Osborn wave is seen in cases of&nbsp;</span></span><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">moderate or severe hypothermia&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">due to&nbsp;</span></span><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">increase in the epicardial potassium current&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">relative to that of endocardium during ventricular repolarization.</span></span></p>",
      "correct_choice_id": 44971,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57164,
      "choices": [
        {
          "id": 228045,
          "text": "<p><span style=\"font-size:12.0pt;\">Labelling error</span></p>"
        },
        {
          "id": 228046,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 228047,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumoperitoneum</span></p>"
        },
        {
          "id": 228048,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely diagnosis? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-164311.jpg\" alt=\"\" width=\"300\" height=\"310\"></span></p>",
      "unique_key": "Q8317590",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341441,
      "difficulty_level": "beginner",
      "subjects_id": [
        17
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Kartagener syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-164311_8IfB9xz.jpg\" alt=\"\" width=\"300\" height=\"310\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome, also known as primary ciliary dyskinesia with situs inversus, is a genetic disorder characterized by a triad of symptoms: bronchiectasis, chronic sinusitis, and situs inversus. The provided image shows clear evidence of situs inversus (with the heart apex and stomach bubble on the right side) and bronchiectasis (dilated bronchi seen on the X-ray). These findings align perfectly with Kartagener syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this image:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The heart apex is seen on the right side, confirming dextrocardia.</span></li><li><span style=\"font-size:12.0pt;\">The stomach bubble is also on the right side, indicating situs inversus.</span></li><li><span style=\"font-size:12.0pt;\">There are multifocal dilated bronchi, which are signs of bronchiectasis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These findings together strongly suggest Kartagener syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Labelling error:</strong> While it is crucial to confirm that the X-ray is correctly labeled (i.e., left and right markers), in this case, the labeling is correct, and the findings of situs inversus, dextrocardia, and bronchiectasis are genuine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pneumoperitoneum:</strong> This condition refers to the presence of air in the peritoneal cavity, which would not present as dextrocardia or bronchiectasis. It is not consistent with the X-ray findings shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cystic fibrosis:</strong> Cystic fibrosis can also present with bronchiectasis, but it does not typically involve situs inversus or dextrocardia, making this an incorrect option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kartagener syndrome is diagnosed based on the triad of situs inversus, bronchiectasis, and chronic sinusitis, often identified by observing the positions of the heart, stomach bubble, and bronchi on imaging.</span></p>",
      "correct_choice_id": 228046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51454,
      "choices": [
        {
          "id": 205333,
          "text": "<p><span style=\"font-size:12.0pt;\">Ibuprofen</span></p>"
        },
        {
          "id": 205334,
          "text": "<p><span style=\"font-size:12.0pt;\">Sumatriptan</span></p>"
        },
        {
          "id": 205335,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 205336,
          "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 58-year-old hypertensive patient with a history of myocardial infarction (MI) presents with an acute attack of migraine. Which of the following medications should not be given for migraine in this patient? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q6743440",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337733,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sumatriptan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sumatriptan belongs to a class of drugs called triptans, which are commonly used to treat migraines. Triptans work by constricting blood vessels in the brain, which helps to relieve migraine pain. However, they can also cause vasoconstriction in other parts of the body, including the coronary arteries. This vasoconstriction can potentially trigger coronary artery spasm, reducing blood flow to the heart and worsening the condition of a patient with a history of myocardial infarction (MI).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Sumatriptan and ergotamine are commonly used in treating migraine attacks by stimulating 5HT1B1D receptors, which induce vasoconstriction in the brain to alleviate migraine symptoms. While this vasoconstriction is beneficial within the brain, it can have harmful effects elsewhere. Both drugs can cause vasoconstriction in peripheral blood vessels and the coronary artery, potentially leading to serious conditions:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Peripheral Vasoconstriction</strong>: Could result in gangrene, with ergotamine having a higher risk than sumatriptan.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Coronary Artery Spasm</strong>: This can exacerbate conditions like myocardial infarction (MI).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ibuprofen</strong>: Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that can be used to manage mild to moderate migraine pain. It does not cause vasoconstriction and is generally safe for patients with a history of MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Propranolol</strong>: Propranolol is a beta-blocker that can be used for migraine prophylaxis (prevention). It does not cause vasoconstriction and can even be beneficial in patients with hypertension, which is a risk factor for both migraine and MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil</strong>: Verapamil is a calcium channel blocker that can also be used for migraine prophylaxis. It has vasodilatory effects and does not pose a risk of coronary artery spasm.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Triptans, such as sumatriptan &amp; ergotamine, are contraindicated in patients with a history of myocardial infarction or other significant cardiovascular diseases due to their potential to cause coronary artery vasoconstriction</span></p>",
      "correct_choice_id": 205334,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73651,
      "choices": [
        {
          "id": 293545,
          "text": "<p><span style=\"font-size:12.0pt;\">Substitution of glutamic acid by valine at position 6 of the α -globin chain</span></p>"
        },
        {
          "id": 293546,
          "text": "<p><span style=\"font-size:12.0pt;\">Substitution of glutamic acid by leucine at position 6 of the β-globin chain</span></p>"
        },
        {
          "id": 293547,
          "text": "<p><span style=\"font-size:12.0pt;\">Substitution of glutamic acid by valine at position 6 of the β-globin chain</span></p>"
        },
        {
          "id": 293548,
          "text": "<p><span style=\"font-size:12.0pt;\">Substitution of glutamic acid by leucine at position 6 of the α-globin chain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which Mutation is seen in sickle cell anemia? (INICET NOV 2024)</span></p>",
      "unique_key": "Q4928403",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337718,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Substitution of glutamic acid by valine at position 6 of the β-globin chain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell anemia is caused by a <strong>point mutation in the β-globin gene (HBB)</strong> located on chromosome 11. This mutation results in the <strong>substitution of glutamic acid with valine at position 6 of the β-globin chain</strong>. The replacement of glutamic acid with a valine causes <strong>polymerization of deoxygenated hemoglobin S (HbS)</strong>, leading to red blood cell sickling, increased rigidity, and vaso-occlusive crises. The sickled cells have reduced deformability and tend to aggregate, causing <strong>vascular obstruction, hemolysis, and ischemia</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Substitution of glutamic acid by valine at position 6 of the α -globin chain:&nbsp;</strong>Incorrect. The mutation in sickle cell anemia affects the β-globin chain, not the α-globin chain. Additionally, while the amino acid substitution involves valine, it occurs at a specific position in the beta chain.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Substitution of glutamic acid by leucine at position 6 of the β-globin chain:&nbsp;</strong>Incorrect. While the position (6th) and initial amino acid (glutamic acid) are correct, the substituting amino acid is valine, not leucine. When lysine replaces glutamic acid, it results in hemoglobin C disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Substitution of glutamic acid by leucine at position 6 of the α-globin chain:&nbsp;</strong>Incorrect. This combines two errors - wrong chain (α instead of β) and wrong substituting amino acid (leucine instead of valine).</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Sickle cell anemia is caused by a point mutation resulting in substitution of <strong>glutamic acid by valine specifically at position 6 of the β-globin chain.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">This results in polymerization of deoxygenated hemoglobin S (HbS), sickling of red blood cells, and complications such as vaso-occlusive crises and hemolysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_JuB3Hjq.png\" width=\"1066\" height=\"322\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>COMPLICATIONS:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Vaso-occlusive crisis: most common clinical complication</span></li><li><span style=\"font-size:16px;\">Aplastic crisis: BM overactivity due to compensatory mechanism → parvovirus infection</span></li><li><span style=\"font-size:16px;\">Sequestration crisis:&nbsp;↑↑↑splenic size leading to hypovolemia</span></li><li><span style=\"font-size:16px;\">Hemolytic crisis- due to infection, splenic macrophage becomes overactive</span></li></ul>",
      "correct_choice_id": 293547,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32292,
      "choices": [
        {
          "id": 129026,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1</span></span></span></span></p>"
        },
        {
          "id": 129027,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2</span></span></span></span></p>"
        },
        {
          "id": 129028,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4</span></span></span></span></p>"
        },
        {
          "id": 129029,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child is presented with multiple times loose stools. He is managed with ORS. Glucose in ORS is absorbed via which transporter in GIT?(NEET PG 2021)</span></span></span></span></p>",
      "unique_key": "Q8139329",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337732,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) SGLT-1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium-Glucose Transporter 1</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is a transporter protein located in the small intestine. It plays a crucial role in the absorption of glucose and sodium from the gut lumen into the enterocytes (intestinal cells). In the context of ORS, SGLT-1 facilitates the absorption of glucose, which helps in the rehydration process by increasing fluid absorption.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose and galactose are absorbed from intestinal lumen into intestinal cell via secondary active transport using sodium dependent glucose transporter (SGLT-1). On the other hand, the glucose from the intestine cell in to blood at basolateral membrane is transported via passive transporter GLUT-2 (see fig)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture9.jpg\" style=\"height:341px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. SGLT-2 (Sodium-Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-2 is primarily found in the proximal renal tubules of the kidney and is responsible for the reabsorption of glucose from the urine. It is not involved in the absorption of glucose from the gastrointestinal tract.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. GLUT-4 (Glucose Transporter 4)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-4 is a glucose transporter primarily found in muscle and adipose tissue. It is responsible for insulin-mediated glucose uptake into these tissues and is not related to glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. GLUT-2 (Glucose Transporter 2)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GLUT-2 is a glucose transporter found in the liver, pancreatic beta cells, and the basolateral membrane of enterocytes. It is involved in glucose uptake by the liver and pancreas and is not the primary transporter for glucose absorption in the gut.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SGLT-1 is the key transporter responsible for the absorption of glucose in the gastrointestinal tract. This mechanism is crucial in the management of conditions like diarrhea, where ORS containing glucose can help rehydrate the body by enhancing fluid absorption.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">-Harper 31<sup>st</sup> e/pg. 538</span></span></strong></span></span></p>",
      "correct_choice_id": 129026,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6004,
      "choices": [
        {
          "id": 23986,
          "text": "<p><span style=\"font-size:12pt;\">Expectant management</span></p>"
        },
        {
          "id": 23987,
          "text": "<p><span style=\"font-size:12pt;\">Single dose methotrexate</span></p>"
        },
        {
          "id": 23988,
          "text": "<p><span style=\"font-size:12pt;\">Salpingectomy</span></p>"
        },
        {
          "id": 23989,
          "text": "<p><span style=\"font-size:12pt;\">Milking of the tube</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient, on treatment for infertility, came with 6 weeks of amenorrhea, abdominal pain, and mild vaginal bleeding. Her beta hCG level was 2800 mlU/mL. On ultrasound, a 3cm mass was seen in the left adnexa. It contained a gestational sac with no fetal cardiac activity. What is the most appropriate management for this patient hCG- Human chorionic gonadotropin?&nbsp;</span>(NEET PG 2021)</p>",
      "unique_key": "Q5931835",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337721,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Single dose methotrexate</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Management of an unruptured ectopic pregnancy can include expectant, medical, or surgical approaches depending on the patient's condition and specific characteristics of the ectopic pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Medical Management (Single Dose Methotrexate):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Methotrexate is a folic acid antagonist that inhibits DNA synthesis, effectively treating ectopic pregnancies by stopping the growth of the trophoblastic tissue.</span></li><li><span style=\"font-size:12pt;\"><strong>Indications for Methotrexate:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Patient hemodynamically stable.</span></li><li><span style=\"font-size:12pt;\">No significant symptoms.</span></li><li><span style=\"font-size:12pt;\">Gestational sac size &lt; 3.5 cm.</span></li><li><span style=\"font-size:12pt;\">No visible cardiac activity.</span></li><li><span style=\"font-size:12pt;\">Serum βhCG &lt; 5000 IU/L.</span></li><li><span style=\"font-size:12pt;\">No contraindication to Methotrexate.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the patient has a beta hCG level of 2800 mIU/mL, a 3 cm mass in the left adnexa, and no fetal cardiac activity, making her an appropriate candidate for single-dose methotrexate therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Expectant management:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Clinically stable with no pain.</span></li><li><span style=\"font-size:12pt;\">Serum βhCG &lt; 1000 IU/L.</span></li><li><span style=\"font-size:12pt;\">Tubal ectopic &lt; 35 mm with no visible heartbeat.</span></li><li><span style=\"font-size:12pt;\">Ability to return for follow-up.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> The patient's beta hCG level is 2800 mIU/mL and she presents with symptoms, thus expectant management is not suitable.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Salpingectomy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Significant pain.</span></li><li><span style=\"font-size:12pt;\">Adnexal mass of 35 mm or larger.</span></li><li><span style=\"font-size:12pt;\">Visible fetal heartbeat on ultrasound.</span></li><li><span style=\"font-size:12pt;\">Serum hCG level of 5000 IU/L or more.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> The patient's ectopic pregnancy size and beta hCG levels do not meet the criteria for surgical intervention. She is hemodynamically stable and a good candidate for medical management.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milking of the tube:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Indications:</strong> Generally not a recommended procedure due to the risk of incomplete removal of trophoblastic tissue and subsequent complications.</span></li><li><span style=\"font-size:12pt;\"><strong>Reason for not choosing:</strong> This option is outdated and not typically recommended for the management of ectopic pregnancies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In a stable patient with an unruptured ectopic pregnancy, beta hCG levels &lt; 5000 IU/L, gestational sac size &lt; 3.5 cm, and no fetal cardiac activity, single-dose methotrexate is the most appropriate management option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 378, William’s Obstetrics 25<sup>th</sup> edition, https://www.nice.org.uk/guidance/ng126</strong></span></p>",
      "correct_choice_id": 23987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55347,
      "choices": [
        {
          "id": 220849,
          "text": "<p><span style=\"font-size:12pt;\">Troponin</span></p>"
        },
        {
          "id": 220850,
          "text": "<p><span style=\"font-size:12pt;\">Ischemia modified albumin</span></p>"
        },
        {
          "id": 220851,
          "text": "<p><span style=\"font-size:12pt;\">LDH</span></p>"
        },
        {
          "id": 220852,
          "text": "<p><span style=\"font-size:12pt;\">CK MB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is earliest to rise in myocardial infarction? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q5319851",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341428,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ischemia modified albumin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the event of a myocardial infarction, certain biomarkers are released into the bloodstream as a result of cardiac muscle injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Among the <strong>three early markers of myocardial injury</strong>, three are particularly significant: <strong>myoglobin, heart-type fatty acid binding protein (HFABP), and ischemia modified albumin (IMA).</strong> Of these three, ischemia modified albumin is the earliest to rise and also the earliest to fall in response to myocardial ischemia. This rapid change makes it a valuable early diagnostic marker for detecting myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Troponin:</strong> Troponins are highly specific markers for myocardial injury and are considered the gold standard for diagnosing myocardial infarction. However, they do not rise as early as ischemia modified albumin. Typically, troponin levels start to rise 4-6 hours after the onset of myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. LDH (Lactate Dehydrogenase):</strong> LDH is an enzyme found in almost all body tissues and is not specific to cardiac tissue. It is a later marker of myocardial infarction, usually rising within 24-48 hours after the onset of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. CK MB (Creatine Kinase-MB):</strong> CK-MB is a specific isoenzyme found in heart muscle and is used as a marker for myocardial infarction. However, it does not rise as early as ischemia modified albumin. CK-MB levels typically start to increase 3-6 hours after myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ischemia modified albumin is the earliest biomarker to rise in the event of a myocardial infarction, making it a crucial early indicator for diagnosis.</span></p>",
      "correct_choice_id": 220850,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19954,
      "choices": [
        {
          "id": 79777,
          "text": "<p><span style=\"font-size:12.0pt;\">Threshold point is at A</span></p>"
        },
        {
          "id": 79778,
          "text": "<p><span style=\"font-size:12.0pt;\">At point E, the nerve is more excitable</span></p>"
        },
        {
          "id": 79779,
          "text": "<p><span style=\"font-size:12.0pt;\">Point C to D is due to opening of Na+ and closure of K+ channels</span></p>"
        },
        {
          "id": 79780,
          "text": "<p><span style=\"font-size:12.0pt;\">Point B to D is refractory period</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True statement regarding the given nerve action potential curve is?</span>(NEET PG 2023)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/whatsapp-image-2023-06-27-at-191615.jpeg\" alt=\"\" width=\"500\" height=\"355\"></p><p>&nbsp;</p>",
      "unique_key": "Q4129850",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341548,
      "difficulty_level": "intermediate",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Point B to D is refractory period</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correct statement regarding the given nerve action potential curve is point B to D is the refractory period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/27/physiology-neet-23-1-6.jpg\" alt=\"\" width=\"700\" height=\"371\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>AT POINT 1 </strong>- Resting membrane potential: membrane is more permeable to K+ than Na+ at rest. Voltage-gated Na+ and K+ channels are closed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>AT POINT 2 - </strong>Membrane depolarization: Na+ activation gate opens à Na+ flows inward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>AT POINT 3 </strong>- Membrane repolarization: Na+ inactivation gate closes at peak potential, thus stopping Na+ inflow. K+ activation gate opens → K+ flows outward.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>AT POINT 4 -</strong> Membrane hyperpolarization: K+ activation gates are slow to close → excess K+ efflux and brief period of hyperpolarization. Voltage-gated Na+ channels switch back to resting state. Na+/K+ pump restores ions concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Point 2 to 4</strong> is a part of the refractory period. During this period, the application of even a stronger stimulus will not elicit an action potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The refractory period is divided into two, an absolute refractory period and a relative refractory period. During the absolute refractory period, the nerve will not be excited no matter how strong a stimulus is given. However, during the relative refractory period, stronger than normal stimuli can cause excitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>: Incorrect. Threshold potential is reached just before point B where a rapid depolarization phase begins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: Incorrect. At point E, the nerve is not more excitable; rather, it is in a hyperpolarized state where more than the normal stimulus would be needed to generate another action potential.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: Incorrect. The transition from C to D is characterized by the closing of Na+ channels and the opening of K+ channels, not the other way around.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The phases of an action potential -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Point A</strong>: Represents the resting membrane potential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Point B</strong>: Marks the threshold potential.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Point C</strong>: Represents the peak of the action potential.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Point D</strong>: Repolarization phase</span></li><li><span style=\"font-size:12.0pt;\"><strong>Point E</strong>: Hyperpolarization phase</span></li><li><span style=\"font-size:12.0pt;\"><strong>Absolute refractory period</strong> includes points B to around point C</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relative refractory period</strong> from around point C to D</span></li></ul>",
      "correct_choice_id": 79780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11292,
      "choices": [
        {
          "id": 45134,
          "text": "<p><span style=\"font-size:12.0pt;\">Kerley B lines</span></p>"
        },
        {
          "id": 45135,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal oligemia</span></p>"
        },
        {
          "id": 45136,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased venous blood in lung</span></p>"
        },
        {
          "id": 45137,
          "text": "<p><span style=\"font-size:12.0pt;\">Change in upper lobe circulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a radiological finding in a patient with left heart failure? (NEET PG 2020)</span></p>",
      "unique_key": "Q4400520",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Focal oligemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Focal oligemia, also known as the Westermark sign, is a radiological finding indicative of pulmonary embolism, not heart failure. It represents a regional reduction in lung vascularity and is seen on chest radiographs as an area of decreased blood flow and enhanced clarity due to vascular obstruction from a clot.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Radiological Findings in Left Heart Failure:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Kerley B lines:&nbsp;</strong>These are thin linear opacities caused by interstitial edema, especially near the lung bases, and are commonly associated with congestive heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased venous blood in lung:&nbsp;</strong>Also known as pulmonary venous hypertension, this finding is due to increased pressure in the pulmonary veins that results from left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Change in upper lobe circulation:&nbsp;</strong>This refers to the redistribution of blood flow to the upper lobes, a classic sign of pulmonary venous hypertension seen in left heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Further Stages of Left Heart Failure on CXR:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Stage 1 (PCWP 13-18 mmHg):&nbsp;</strong>Cardiomegaly, redistribution of pulmonary vessels, broad vascular pedicle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 2 (PCWP 18-25 mmHg):&nbsp;</strong>Kerley B lines and peribronchial cuffing indicating interstitial edema.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stage 3 (PCWP &gt; 25 mmHg):&nbsp;</strong>Alveolar edema leading to consolidation and pleural effusion.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In patients with suspected heart failure, radiological findings such as Kerley B lines, increased pulmonary venous pressure, and altered upper lobe circulation are indicative. Focal oligemia, however, suggests a differential diagnosis of pulmonary embolism and should prompt further investigation for this condition rather than heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/24/screenshot-2024-07-24-114523.jpg\" alt=\"\" width=\"929\" height=\"740\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Radiology assistant/ CXR in heart failure</strong></span></p>",
      "correct_choice_id": 45135,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11350,
      "choices": [
        {
          "id": 45366,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flunarizine</span></span></p>"
        },
        {
          "id": 45367,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan</span></span></p>"
        },
        {
          "id": 45368,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propranolol</span></span></p>"
        },
        {
          "id": 45369,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topiramate</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female patient presents to you with a unilateral headache. It is associated with nausea, photophobia, and phonophobia. What is the best drug for acute management? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q1883460",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337716,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&rsquo;s symptoms of unilateral headache accompanied by nausea, photophobia, and phonophobia are classic indicators of a migraine. Migraine is a common condition in young females and can be associated with other symptoms such as primary Raynaud&#39;s phenomenon.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For the acute management of migraines</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Mild to moderate attacks &ndash; Paracetamol or NSAIDs like Ketorolac.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Moderate to severe attacks - Triptans are the drugs of choice. Other group of drugs are Ditans/ Gepants</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sumatriptan, <span style=\"background-color:white\"><span style=\"color:black\">Rizatriptan</span></span> a commonly used triptan, is a 5HT 1B/1D agonist which effectively alleviates migraine symptoms by causing vasoconstriction of the dilated blood vessels thought to be responsible for migraine pain. This action helps to reduce the headache and associated symptoms rapidly. - </span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">All of these drugs are contraindicated in the setting of pregnancy&nbsp;except paracetamol. Triptans are unsafe in vascular conditions</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ditans</span></strong><span style=\"font-size:12.0pt\"> (Ex.</span><span style=\"font-size:12.0pt\"> Lasmiditan) are 5-HT1F receptor agonists. Unlike triptans, they do not cause vasoconstriction, making them safer for patients with vascular conditions such as coronary artery disease or peripheral arterial disease. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Gepents</strong> are CGRP (calcitonin gene-related peptide) antagonists or blocker. Gepents, including rimegepant, atogepant, ubrogepant, and zabigipant, are effective in migraine management. These are oral medications and do not cause vasoconstriction, which also makes them suitable for patients with certain vascular conditions.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note - Dopamine Receptor Blockers</span></strong><span style=\"font-size:12.0pt\">: Prochlorperazine is mentioned as an example of this class. While not the focus of the discussion, dopamine receptor blockers are noted as effective in managing migraines.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Flunarizine:</strong> Flunarizine is a calcium channel blocker used primarily for the prophylactic (preventive) treatment of migraines, not for acute management. It helps in reducing the frequency of migraine attacks but does not relieve symptoms once an attack has started.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Propranolol:</span></strong><span style=\"font-size:12.0pt\"> Propranolol is a beta-blocker used for the prophylaxis of migraines. It is effective in reducing the frequency and severity of migraine attacks over time but is not used for immediate relief during an acute migraine episode.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Topiramate:</span></strong><span style=\"font-size:12.0pt\"> Topiramate is an anticonvulsant medication also used for the prophylactic treatment of migraines. Similar to propranolol, it helps prevent migraines but is not effective in treating acute migraine symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sumatriptan is the drug of choice for the acute management of moderate to severe migraine attacks due to its vasoconstrictive properties and effectiveness in rapidly alleviating migraine symptoms.</span></span></p>",
      "correct_choice_id": 45367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20346,
      "choices": [
        {
          "id": 81345,
          "text": "<p><span style=\"font-size:18px;\">Retrospective cohort study</span></p>"
        },
        {
          "id": 81346,
          "text": "<p><span style=\"font-size:18px;\">Prospective cohort study</span></p>"
        },
        {
          "id": 81347,
          "text": "<p><span style=\"font-size:18px;\">Case-control study</span></p>"
        },
        {
          "id": 81348,
          "text": "<p><span style=\"font-size:18px;\">Intervention and response</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>Research is being conducted to find the association between aniline dye exposure and bladder cancer in workers who have worked in the industry for &gt;20 years. Two groups were formed: one directly involved with dye handling and the other group consisting of office clerks not directly exposed to the dye. Years of occupation were noted from records. Then Bladder cancer cases were identified from both the groups in the current time. What type of study is being performed? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
      "unique_key": "Q5368683",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337726,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Retrospective cohort study</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The study given here is a retrospective cohort study.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A retrospective cohort study is when both the exposure and outcome have occurred before commencing the investigations and study.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The given question tells that the workers in the industry were divided into two groups, first are those who are directly exposed and second are clerical staff who are not directly exposed to the suspected carcinogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The incidence of bladder cancer among these two groups is studied going backward tracking their records. Therefore, it’s a retrospective cohort study.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A simple comparison between these studies and an example is shown below:</span><br><span style=\"font-size:18px;\">&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-094133.png\" alt=\"\" width=\"1000\" height=\"209\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Prospective cohort study:&nbsp;</strong>Involves following a group over a time span till the development of outcome.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Case-control study:</strong>&nbsp;A case-control study involves comparing groups with a specific outcome (cases) with a rather healthy group (controls) and assessing their exposure history. In this case, workers are divided into groups based on their exposure status and the development of bladder cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Intervention and response: </strong>Is not a type of epidemiological study design.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">A retrospective cohort study involves examining historical data to investigate the relationship between exposure and outcomes. In this scenario, it is used to study the association between aniline dye exposure and bladder cancer among workers over a 20-year period.</span></p>",
      "correct_choice_id": 81345,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73010,
      "choices": [
        {
          "id": 291005,
          "text": "<p><span style=\"font-size:16px;\">Buccopharyngeal fascia</span></p>"
        },
        {
          "id": 291006,
          "text": "<p><span style=\"font-size:16px;\">Pharyngobasilar fascia</span></p>"
        },
        {
          "id": 291007,
          "text": "<p><span style=\"font-size:16px;\">Alar fascia</span></p>"
        },
        {
          "id": 291008,
          "text": "<p><span style=\"font-size:16px;\">Prevertebral fascia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Identify the marked structure:&nbsp;(FMGE JAN 2025)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-26%20172348.jpg\" width=\"542\" height=\"611\"></span></p>",
      "unique_key": "Q2615841",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337731,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. A) Buccopharyngeal fascia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:16px;\">&nbsp;The marked structure is buccopharyngeal fascia based on its anatomical position:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Located behind the muscular layer of pharynx</span></li><li><span style=\"font-size:16px;\">Forms outer covering of pharyngeal muscles</span></li><li><span style=\"font-size:16px;\">Lies anterior to retropharyngeal space</span></li><li><span style=\"font-size:16px;\">Follows the arrangement of pharyngeal wall layers from inside out:&nbsp;</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:16px;\">Pharyngobasilar fascia (innermost)</span></li><li><span style=\"font-size:16px;\">Muscular layer (longitudinal and circular)</span></li><li><span style=\"font-size:16px;\">Buccopharyngeal fascia</span></li><li><span style=\"font-size:16px;\">Retropharyngeal space</span></li><li><span style=\"font-size:16px;\">Alar fascia</span></li><li><span style=\"font-size:16px;\">Alar space</span></li><li><span style=\"font-size:16px;\">Prevertebral fascia</span></li><li><span style=\"font-size:16px;\">Prevertebral space</span></li><li><span style=\"font-size:16px;\">Vertebra</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Pharyngobasilar fascia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Forms innermost layer lining pharyngeal cavity</span></li><li><span style=\"font-size:16px;\">Located beneath mucosa</span></li><li><span style=\"font-size:16px;\">Forms tonsillar capsule posteriorly</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Alar fascia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Located posterior to retropharyngeal space</span></li><li><span style=\"font-size:16px;\">Forms anterior boundary of danger space</span></li><li><span style=\"font-size:16px;\">Extends to T4 vertebral level</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Prevertebral fascia</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Located most posteriorly before vertebral column</span></li><li><span style=\"font-size:16px;\">Forms posterior boundary of danger space</span></li><li><span style=\"font-size:16px;\">Extends to coccyx</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-02-26%20172438.jpg\" width=\"1254\" height=\"433\"></strong></span></p>",
      "correct_choice_id": 291005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51950,
      "choices": [
        {
          "id": 207313,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae</span></p>"
        },
        {
          "id": 207314,
          "text": "<p><span style=\"font-size:12.0pt;\">Neisseria meningitidis</span></p>"
        },
        {
          "id": 207315,
          "text": "<p><span style=\"font-size:12.0pt;\">Histoplasma capsulatum</span></p>"
        },
        {
          "id": 207316,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus neoformans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following organisms are encapsulated except: (NEET PG 2015)</span></p>",
      "unique_key": "Q2951290",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337720,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. Histoplasma capsulatum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Histoplasma capsulatum</strong> is not an encapsulated organism despite its name suggesting otherwise. The term \"capsulatum\" in its name is misleading as this fungus does not produce a true capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. Streptococcus pneumoniae</strong> - This is a capsulated bacterium with a well-defined polysaccharide capsule. The capsule is a major virulence factor for pneumococci and is the basis for serotyping. The capsule helps the organism resist phagocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Neisseria meningitidis</strong> - Meningococci possess a polysaccharide capsule that is essential for their virulence. The capsule protects the organism from phagocytosis and complement-mediated killing. It's also used for serological classification.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Cryptococcus neoformans</strong> - This fungus has a prominent polysaccharide capsule that is a major virulence factor. The capsule can be visualized by India ink preparation, appearing as a clear halo around the yeast cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bacterial and fungal capsules are important virulence factors that primarily function to inhibit phagocytosis, allowing pathogens to evade host immune responses. Despite its name, Histoplasma capsulatum lacks a true capsule, unlike the other organisms listed which all possess well-defined capsular structures.</span></p>",
      "correct_choice_id": 207315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11245,
      "choices": [
        {
          "id": 44946,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inflammatory condition</span></span></p>"
        },
        {
          "id": 44947,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Descending paralysis is seen</span></span></p>"
        },
        {
          "id": 44948,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasmapheresis is a treatment method</span></span></p>"
        },
        {
          "id": 44949,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Demyelinating disorder</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All are true about Typical Guillain-Barre syndrome except: (NEET PG 2019)</span></span></p>",
      "unique_key": "Q8290426",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341427,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Descending paralysis is seen</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guillain-Barre Syndrome (GBS) is typically characterized by ascending paralysis, starting from the lower extremities and moving upward, not descending paralysis. This pattern begins with weakness in the legs that spreads to the upper limbs and the face, associated with the demyelination of peripheral nerves. The condition is indeed inflammatory and primarily affects the peripheral nervous system, leading to demyelination and sometimes axonal damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inflammatory condition:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS is an acute inflammatory demyelinating polyneuropathy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasmapheresis is a treatment method:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, plasmapheresis is used to remove antibodies from the blood that are thought to be involved in the immune attack on the peripheral nerves.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Demyelinating disorder:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True, GBS involves the demyelination of peripheral nerves, leading to muscle weakness and paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GBS produces neuro-radiculopathy due to demyelination causing ascending paralysis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Causes of Descending paralysis (<strong>Mnemonic: Bipolar disorder [BPD]</strong>):</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B: B</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">otulism</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P: P</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">orphyria, Polio</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D: D</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">iphtheria</span></span></span></span></p>",
      "correct_choice_id": 44947,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44058,
      "choices": [
        {
          "id": 175887,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine</span></span></span></span></p>"
        },
        {
          "id": 175888,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine</span></span></span></span></p>"
        },
        {
          "id": 175889,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Belladona</span></span></span></span></p>"
        },
        {
          "id": 175890,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amanita phylloides</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which toxin can cause acute liver failure and hematuria? (FMGE JANUARY 2024)</span></span></p>",
      "unique_key": "Q5300276",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341442,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Amanita phylloides</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amanita phylloides, also known as the &quot;death cap&quot; mushroom, contains toxins that can cause both acute liver failure and hematuria. The mushroom contains amatoxins, which are responsible for the severe liver damage, and can also affect the kidneys, leading to renal damage and hematuria. This combination of liver and kidney damage is a characteristic feature of Amanita phylloides poisoning.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/17/screenshot-2024-05-17-112919.JPG\" style=\"height:202px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. A. Morphine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morphine is an opioid that can cause respiratory depression and constipation, but it is not typically associated with acute liver failure and hematuria.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. B. Ketamine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine is an anesthetic that can cause dissociative effects and hallucinations, but it is not known to cause acute liver failure and hematuria.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option. C. Belladonna:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropa Belladonna, also known as deadly nightshade, contains anticholinergic compounds that can cause symptoms such as dry mouth, blurred vision, and tachycardia. However, it is not associated with acute liver failure and hematuria.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/17/screenshot-2024-05-17-112939.JPG\" style=\"height:299px; width:300px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amanita phylloides, or the &quot;death cap&quot; mushroom, is a toxin that can cause both acute liver failure and hematuria due to the presence of amatoxins. This combination of liver and kidney damage is a characteristic feature of Amanita phylloides poisoning</span></span></span></span></p>",
      "correct_choice_id": 175890,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5610,
      "choices": [
        {
          "id": 22412,
          "text": "<p><span style=\"font-size:12.0pt;\">Lead</span></p>"
        },
        {
          "id": 22413,
          "text": "<p><span style=\"font-size:12.0pt;\">Arsenic</span></p>"
        },
        {
          "id": 22414,
          "text": "<p><span style=\"font-size:12.0pt;\">Thallium</span></p>"
        },
        {
          "id": 22415,
          "text": "<p><span style=\"font-size:12.0pt;\">Mercury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A middle aged man from West Bengal presents with paraesthesia of hands and feet, hyperkeratosis, lines in the nails and rain drop pigmentation in the hands. The most likely causative toxin for the above mentioned symptoms is:</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q9028887",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341550,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Arsenic</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>The symptoms mentioned in the question are classic features of chronic arsenic poisoning.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chronic Arsenic poisoning:&nbsp;</strong>It is insidious in nature. The onset of symptoms usually&nbsp; occurs&nbsp; after 2–8&nbsp; weeks of exposure.&nbsp; Chronic&nbsp; poisoning&nbsp; may&nbsp; occur among persons engaged in smelting and refining of ores and in the subliming of arsenic in the manufacture of weed killers, dyes etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Features of Chronic Arsenic poisoning:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>GIT symptoms:&nbsp;</strong>loss of weight, malaise, loss of appetite, salivation, colicky pain, diarrhoea and vomiting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Liver:&nbsp;</strong>Hepatomegaly, jaundice, cirrhosis</span></li><li><span style=\"font-size:12.0pt;\"><strong>Skin symptoms:&nbsp;</strong>usually begin with a persistent erythematous flush leading to <strong>hyperkeratotic skin</strong> and desquamation. Hyperkeratosis is most prominent in the <strong>distal parts of the body</strong>. Pigmentation is patchy <strong>(‘raindrops pigmentation)</strong>. <strong>Skin cancer</strong> (Squamous cell carcinoma and basal cell carcinoma) also occurs.</span></li><li><span style=\"font-size:12pt;\"><strong>Nails:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Aldrich Mees lines</strong> (transverse&nbsp; white&nbsp; striae&nbsp; of&nbsp; the fingernails) may also be seen.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hairs: Alopecia occurs</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Hematological: Anemia, leukopenia, Thrombocytopenia and Bone marrow hypoplasia&nbsp;</strong>are&nbsp; seen.&nbsp; Anemia is normocytic and normochromic</span></li><li><span style=\"font-size:12.0pt;\"><strong>&nbsp;Peripheral&nbsp;neuropathy: Sensory&nbsp; and&nbsp; motor&nbsp; polyneuritis (sensory&nbsp; symptoms&nbsp; usually&nbsp; predominate)&nbsp;</strong> manifesting&nbsp; as numbness and tingling in a <strong>‘stocking glove’ </strong>distribution.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Blackfoot disease:&nbsp;</strong>Due to platelet activation and hypercoagulability of blood in peripheral arteries.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Encephalopathy</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Nephritis</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lead: </strong>Symptoms&nbsp;Abdominal pain, anemia, neurological deficits, but not specifically hyperkeratosis, Mees lines, or raindrop pigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thallium: </strong>Symptoms&nbsp;Gastrointestinal disturbances, alopecia, peripheral neuropathy, but lacks the specific skin changes and nail lines associated with arsenic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mercury: </strong>Symptoms<strong>:&nbsp;</strong>Tremors, memory loss, gingivitis, and neurological symptoms, but does not cause hyperkeratosis or Mees lines.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic arsenic poisoning presents with distinctive symptoms such as paraesthesia, hyperkeratosis, Aldrich Mees lines, and raindrop pigmentation, making it the most likely cause of the described symptoms.</span></p>",
      "correct_choice_id": 22413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56036,
      "choices": [
        {
          "id": 223573,
          "text": "<p><span style=\"font-size:12pt;\">Treponema pallidum</span></p>"
        },
        {
          "id": 223574,
          "text": "<p><span style=\"font-size:12pt;\">Malassezia furfur</span></p>"
        },
        {
          "id": 223575,
          "text": "<p><span style=\"font-size:12pt;\">Staphylococcus aureus</span></p>"
        },
        {
          "id": 223576,
          "text": "<p><span style=\"font-size:12pt;\">Microsporum canis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A 27-year-old male came with complaints of asymptomatic generalized papulosquamous rash on trunk, moist flat grey perianal lesions and hair loss as given below. What is the most likely causative organism? (NEET PG 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/05/screenshot-2024-09-05-105319.png\" alt=\"\" width=\"350\" height=\"407\"></span></p>",
      "unique_key": "Q2193306",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Treponema pallidum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with several key clinical features: asymptomatic generalized papulosquamous rash on the trunk, moist flat grey perianal lesions (<strong>condyloma lata</strong>), and patchy hair loss. The patchy hair loss, described as \"<strong>moth-eaten alopecia</strong>,\" is a characteristic feature of <strong>secondary syphilis.</strong> These signs are strongly indicative of an infection caused by Treponema pallidum, the bacterium responsible for syphilis. The presence of condyloma lata and the specific type of alopecia observed are classical clues pointing towards this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>DD of Patchy Alopecia – Alopecia areata, Tinea capitis, Trichotillomania, and Secondary Syphilis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Malassezia furfur:&nbsp;</strong>This organism is associated with conditions like pityriasis versicolor and seborrheic dermatitis, neither of which typically present with the described combination of symptoms, particularly the moth-eaten alopecia and condyloma lata.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Staphylococcus aureus:&nbsp;</strong>While Staphylococcus aureus can cause skin infections and folliculitis, it does not typically cause the type of patchy alopecia or the other systemic symptoms described in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Microsporum canis:&nbsp;</strong>This is a dermatophyte that causes tinea capitis, which can lead to patchy hair loss. However, tinea capitis would be associated with scaly patches and other signs of fungal infection rather than the systemic features like condyloma lata seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The \"moth-eaten alopecia\" is a key diagnostic feature of secondary syphilis, and Treponema pallidum is the causative organism.</span></p>",
      "correct_choice_id": 223573,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13884,
      "choices": [
        {
          "id": 55497,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterovirus 68</span></p>"
        },
        {
          "id": 55498,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterovirus 69</span></p>"
        },
        {
          "id": 55499,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterovirus 70</span></p>"
        },
        {
          "id": 55500,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterovirus 71</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 32-year-old male patient came with complaints of sudden onset ocular pain and haemorrhagic discharge accompanied with diminution of vision. He is suspected to have acute haemorrhagic conjunctivitis. What is the causative organism? (NEET PG 2018)</span></p>",
      "unique_key": "Q3716154",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337723,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Enterovirus 70</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acute hemorrhagic conjunctivitis is caused by enterovirus 70, a picornavirus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/06/type-of-astigmatism_page_2.jpg\" alt=\"\" width=\"1000\" height=\"1415\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/06/picture2000.jpg\" alt=\"\" width=\"400\" height=\"142\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Enterovirus 68:</strong> Known to cause respiratory illnesses and has been associated with acute flaccid myelitis, but not typically with hemorrhagic conjunctivitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Enterovirus 69:</strong> Less commonly associated with conjunctivitis and more related to respiratory infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Enterovirus 71:</strong> Known to cause hand, foot, and mouth disease and severe neurological diseases, but not typically associated with hemorrhagic conjunctivitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Enterovirus 70 is the primary causative organism of acute hemorrhagic conjunctivitis, characterized by sudden onset of ocular pain, redness, and hemorrhagic discharge. The condition is highly contagious and typically self-limiting, with supportive care being the mainstay of treatment.</span></p>",
      "correct_choice_id": 55499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10452,
      "choices": [
        {
          "id": 41774,
          "text": "<p><span style=\"font-size:12.0pt;\">Telomere stability is associated with aging</span></p>"
        },
        {
          "id": 41775,
          "text": "<p><span style=\"font-size:12.0pt;\">Abnormal telomerase activation is associated with aging</span></p>"
        },
        {
          "id": 41776,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased telomere length is associated with aging</span></p>"
        },
        {
          "id": 41777,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased telomere length is associated with aging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the correct statement regarding the telomerase theory of aging?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2022)</span></p>",
      "unique_key": "Q7718852",
      "question_audio": null,
      "question_video": null,
      "map_id": 29336694,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Decreased telomere length is associated with aging.</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Telomeres are short, TG-rich repeated DNA sequences found at the ends of linear eukaryotic chromosomes. Telomeres do not contain any protein coding sequences. They are necessary for the complete replication of chromosome ends as well as the protection of the ends from fusion and degradation.</span></li><li><span style=\"font-size:12.0pt;\">Telomeres at the ends of chromosomes are normally shortened with each cell division. Cell-cycle arrest or apoptosis may result if telomeres are shortened beyond a certain point. This is referred to as replicative senescence.</span></li><li><span style=\"font-size:12.0pt;\">Telomerase is an enzyme that prevents telomeres from shortening. It is a specialized RNA-protein complex that adds nucleotides to the ends of chromosomes by using its own RNA as a template.</span></li><li><span style=\"font-size:12.0pt;\">This enzyme is found in germ cells but not in most somatic cells. As a result, the majority of somatic cells age, their telomeres shorten, and they exit the cell cycle, rendering them unable to generate new cells to replace damaged cells.</span></li><li><span style=\"font-size:12.0pt;\">In somatic cells, abnormal telomerase reactivation causes senescence and apoptosis. It allows the cells to divide more than usual.</span></li><li><span style=\"font-size:12.0pt;\">Telomerase is usually reactivated in stem cells and cancer cells, and telomere length is stabilized, allowing the cells to proliferate indefinitely.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Decreased telomere length is associated with aging. Telomeres shorten with each cell division, leading to cell-cycle arrest or apoptosis when they become critically short, contributing to the aging process. Telomerase helps prevent this shortening but is typically inactive in most somatic cells, leading to aging and limited cell division capability.</span></p>",
      "correct_choice_id": 41776,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72659,
      "choices": [
        {
          "id": 289625,
          "text": "<p><span style=\"font-size:16px;\">Soft systolic murmur</span></p>"
        },
        {
          "id": 289626,
          "text": "<p><span style=\"font-size:16px;\">Diastolic murmur</span></p>"
        },
        {
          "id": 289627,
          "text": "<p><span style=\"font-size:16px;\">S3</span></p>"
        },
        {
          "id": 289628,
          "text": "<p><span style=\"font-size:16px;\">Loud S1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is an abnormal cardiovascular system examination finding during pregnancy? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q4735296",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341553,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Diastolic murmur</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">During pregnancy, several cardiovascular changes occur as <strong>normal physiological adaptations.</strong> However, a <strong>diastolic murmur is never considered normal</strong> and always requires further evaluation. Any diastolic murmur detected during pregnancy needs <strong>thorough investigation as it may indicate underlying cardiac pathology.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Soft systolic murmur: Incorrect</strong> <strong>because</strong> systolic murmurs are commonly heard during pregnancy due to increased blood volume and cardiac output. They are considered a normal physiological finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. S3 (Third heart sound): Incorrect because</strong> S3 can be heard as a normal finding during pregnancy due to increased blood volume and ventricular filling.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Loud S1 (First heart sound): Incorrect because</strong> a loud S1 is a normal cardiovascular finding during pregnancy due to changes in cardiac position and increased blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">While systolic murmurs, S3, and loud S1 are normal cardiovascular examination findings in pregnancy, any diastolic murmur is always pathological and requires evaluation.</span></p>",
      "correct_choice_id": 289626,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72659/FMGE_Jan_2025_OBG_Q_-_19.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72659/FMGE_Jan_2025_OBG_Q_-_19.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11266,
      "choices": [
        {
          "id": 45030,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal pressure hydrocephalus</span></p>"
        },
        {
          "id": 45031,
          "text": "<p><span style=\"font-size:12.0pt;\">Frontotemporal dementia</span></p>"
        },
        {
          "id": 45032,
          "text": "<p><span style=\"font-size:12.0pt;\">Parkinson disease</span></p>"
        },
        {
          "id": 45033,
          "text": "<p><span style=\"font-size:12.0pt;\">Creutzfeldt-Jakob disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An elderly woman is brought to the OPD with complaints of behavioral change, a history of multiple falls, urinary incontinence, and dementia. What is your diagnosis? (NEET PG 2020)</span></p>",
      "unique_key": "Q1090654",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341436,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A.</strong> <strong>Normal pressure hydrocephalus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Normal pressure hydrocephalus (NPH) is characterized by the triad of dementia, gait disturbance (typically apraxia or magnetic gait), and urinary incontinence. This condition often involves enlargement of the cerebral ventricles due to cerebrospinal fluid accumulation, which can exert pressure on surrounding brain structures, particularly affecting the frontal lobes responsible for cognitive and urinary control. The clinical presentation aligns well with the symptoms described in the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Frontotemporal dementia:</strong> This condition often presents with prominent personality changes and language difficulties rather than the classic triad seen in NPH. Falls are less commonly associated with this form of dementia in its early stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Parkinson disease:</strong> Typically presents with motor symptoms such as tremors, rigidity, and bradykinesia. While dementia can occur in later stages, it is not typically accompanied by urinary incontinence and would not explain the early presence of falls as the primary symptom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Creutzfeldt-Jakob disease:</strong> Known for rapid progression of neurological symptoms including dementia, myoclonus (sudden muscle spasms), and significant motor dysfunction. It progresses much faster than what is typically seen in NPH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NPH is characterized by Dementia, Apraxia/Magnetic gait with urinary incontinence due to frontal lobe dysfunction</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Dementia/Chap 434</strong></span></p>",
      "correct_choice_id": 45030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57020,
      "choices": [
        {
          "id": 227469,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osiander</span></span></span></p>"
        },
        {
          "id": 227470,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chadwick</span></span></span></p>"
        },
        {
          "id": 227471,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Goodell</span></span></span></p>"
        },
        {
          "id": 227472,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hegar</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Patient experiences softening of the cervix in early pregnancy. This sign is called as? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q8486294",
      "question_audio": null,
      "question_video": null,
      "map_id": 29336693,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Goodell</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Goodell&#39;s sign refers to the softening of the cervix, which is observed during early pregnancy. This sign occurs due to increased vascularization and changes in the connective tissue of the cervix, making it feel softer compared to the non-pregnant state, where the cervix feels firm like the tip of the nose.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Osiander:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Osiander&rsquo;s sign refers to the <strong>palpable pulsation of the </strong>uterine arteries felt through the <strong>lateral fornices </strong>during a vaginal examination in early pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Chadwick:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Chadwick&#39;s sign, also known as Jacquemier&rsquo;s sign, is the <strong>bluish discoloration of the vaginal mucosa</strong> and cervix due to increased blood flow during early pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hegar:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This is incorrect. Hegar&#39;s sign involves the softening of the lower uterine segment, which is palpable during a bimanual examination, allowing the examiner&#39;s fingers to approximate between the uterus and the cervix.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Goodell&#39;s sign is the softening of the cervix, observed in early pregnancy due to increased vascularity, which makes the cervix feel soft, like the lips, compared to its usual firm texture</span></span></p>",
      "correct_choice_id": 227471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83975,
      "choices": [
        {
          "id": 334484,
          "text": "<p style=\"margin-left:3.0pt;\"><span style=\"font-size:16px;\">Pulse oximetry</span></p>"
        },
        {
          "id": 334485,
          "text": "<p style=\"margin-left:3.0pt;\"><span style=\"font-size:16px;\">Colour doppler</span></p>"
        },
        {
          "id": 334486,
          "text": "<p style=\"margin-left:3.0pt;\"><span style=\"font-size:16px;\">Bispectral imaging</span></p>"
        },
        {
          "id": 334487,
          "text": "<p style=\"margin-left:3.0pt;\"><span style=\"font-size:16px;\">End tidal CO₂</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">During a surgical procedure, a patient's level of consciousness and awareness under anesthesia is most accurately monitored using: (NEET PG 2016)</span></p>",
      "unique_key": "Q1280220",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Bispectral Imaging (BIS Monitoring)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Bispectral index (BIS) monitoring is specifically designed to assess the <strong>depth of anesthesia</strong> by analyzing the patient’s <strong>electroencephalogram (EEG)</strong>. It provides a <strong>numerical score from 0 to 100</strong>, correlating with levels of consciousness:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>0–40:</strong> Deep anesthesia</span></li><li><span style=\"font-size:16px;\"><strong>40–60:</strong> Optimal range for surgical anesthesia</span></li><li><span style=\"font-size:16px;\"><strong>60–100:</strong> Increasing levels of consciousness</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\">Because BIS monitoring directly reflects <strong>brain electrical activity</strong>, it is considered the <strong>most accurate and objective tool</strong> for evaluating a patient’s level of awareness during anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Pulse Oximetry:&nbsp;</strong>Measures <strong>oxygen saturation (SpO₂)</strong> and <strong>heart rate</strong>, essential for monitoring oxygenation, but it offers <strong>no insight into the depth of anesthesia</strong> or consciousness.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Colour Doppler:</strong> A diagnostic tool for assessing <strong>blood flow in vessels</strong> using ultrasound. It plays <strong>no role</strong> in monitoring anesthesia depth or patient awareness.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. End-Tidal CO₂ (Capnography):</strong> Monitors the <strong>exhaled carbon dioxide</strong> to assess <strong>ventilation status</strong> and confirm <strong>airway placement</strong>, but it does <strong>not assess consciousness or brain activity</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Bispectral index (BIS) monitoring is the gold standard for assessing depth of anesthesia</strong>, offering a reliable, real-time measure of brain activity that guides anesthetic dosing and reduces the risk of intraoperative awareness.</span></p>",
      "correct_choice_id": 334486,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48425,
      "choices": [
        {
          "id": 193291,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperuricemia</span></p>"
        },
        {
          "id": 193292,
          "text": "<p><span style=\"font-size:12.0pt;\">Self-mutilative behavior</span></p>"
        },
        {
          "id": 193293,
          "text": "<p><span style=\"font-size:12.0pt;\">Compulsive aggression</span></p>"
        },
        {
          "id": 193294,
          "text": "<p><span style=\"font-size:12.0pt;\">Caused by mutation in HPRT gene on chromosome 6</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements about Lesch-Nyhan syndrome are true, except: (NEET PG 2017)</span></p>",
      "unique_key": "Q7509080",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337730,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans.&nbsp;D) Caused by mutation in HPRT gene on chromosome 6</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Lesch-Nyhan syndrome is caused by a mutation in the HPRT or HGPRT (Hypoxanthine-guanine phosphoribosyl transferase) gene, which is located on the X chromosome, not on chromosome 6. This X-linked inheritance pattern explains why the condition predominantly affects males. HGPRT is an enzyme involved in the purine salvage pathway, which allows the body to recycle purines rather than synthesizing them de novo. When this enzyme is deficient, PRPP levels increase, resulting in purine overproduction and subsequent hyperuricemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Hyperuricemia:</strong> This is correct. Lesch-Nyhan syndrome is characterized by hyperuricemia due to increased nitrogenous bases leading to elevated uric acid levels, which can cause gout-like symptoms and uric acid lithiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Self-mutilative behavior:</strong> This is correct. Self-mutilation is a characteristic feature of Lesch-Nyhan syndrome, resulting from the neurotoxic effects of increased PRPP levels in the brain.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Compulsive aggression:&nbsp;</strong>This is correct. The neurological manifestations of the syndrome include compulsive aggressive behaviors, which are part of the spectrum of self-injurious behaviors.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Lesch-Nyhan syndrome results from complete deficiency of HGPRT (an enzyme in the purine salvage pathway) located on the X chromosome, causing both elevated uric acid levels (gout) and neurological manifestations including self-mutilation due to neurotoxic PRPP accumulation.</span></p>",
      "correct_choice_id": 193294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13897,
      "choices": [
        {
          "id": 55549,
          "text": "<p><span style=\"font-size:12.0pt;\">Proptosis</span></p>"
        },
        {
          "id": 55550,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudoptosis</span></p>"
        },
        {
          "id": 55551,
          "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
        },
        {
          "id": 55552,
          "text": "<p><span style=\"font-size:12.0pt;\">Pupillary dysfunction</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 68-year-old male patient, who is a known case of diabetes mellitus since the past 25 years, came for a health checkup. He was found to have uncontrolled blood sugar levels and third cranial nerve palsy. Which is the most common feature of third nerve palsy seen in such a case?</span></p>",
      "unique_key": "Q1662063",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341426,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Ptosis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Diabetic oculomotor nerve palsy is caused by hyperglycemia-induced damage to nerve cells and neuronal ischemic change.</span></li><li><span style=\"font-size:12.0pt;\">The arrangement of the fibers in the third cranial nerve is such that the fibers controlling the pupillary reflex are superficial and often spared from diabetic ischemia-induced injury.</span></li><li><span style=\"font-size:12.0pt;\">Pupillary dysfunction is not commonly present in diabetic oculomotor nerve palsy.</span></li><li><span style=\"font-size:12.0pt;\">The levator palpebrae superiors and most of the oculomotor muscles, except for the lateral rectus and superior oblique, are damaged in diabetic oculomotor nerve palsy.</span></li><li><span style=\"font-size:12.0pt;\">Diabetic oculomotor nerve palsy typically presents with ptosis and diplopia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>APPLIED ANATOMY OF PUPILLOMOTOR NERVE FIBRES</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/06/whatsapp-image-2023-11-06-at-190003.jpeg\" alt=\"\" width=\"583\" height=\"542\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Proptosis:</strong> Protrusion of the eye, not typically associated with diabetic oculomotor nerve palsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pseudoptosis:</strong> False appearance of ptosis, not related to actual muscle dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pupillary dysfunction:</strong> Although part of the oculomotor nerve's function, it is usually spared in diabetic oculomotor nerve palsy due to the peripheral location of the pupillary fibers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ptosis (drooping of the upper eyelid) is the most common feature of third nerve palsy seen in diabetic patients, due to the selective ischemic damage to the central fibers of the oculomotor nerve, sparing the peripheral pupillary fibers.</span></p>",
      "correct_choice_id": 55551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10443,
      "choices": [
        {
          "id": 41738,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular Iymphoma</span></p>"
        },
        {
          "id": 41739,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt lymphoma</span></p>"
        },
        {
          "id": 41740,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycosis fungoides</span></p>"
        },
        {
          "id": 41741,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old patient presents to the outpatient department with fatigue, tiredness and cervical lymphadenopathy. The TLC and DLC were normal. No immature cells. A lymph node biopsy was performed which shows diffuse effacement of the Lymph node architecture, cells with an indented nucleus, prominent nucleolus, and are atypical. CD10 and BCL2 are positive. What is the likely diagnosis? (NEET PG 2021)</span></p>",
      "unique_key": "Q4828106",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337735,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Follicular lymphoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical scenario presented here, which includes fatigue, tiredness, and cervical lymphadenopathy with CD10 positive BCL2 positive cells, strongly suggests follicular lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most common type of indolent NHL is follicular lymphoma. It usually appears in middle age and affects both men and women equally. The tumour is most likely caused by germinal centre B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A (14;18) translocation&nbsp;</strong>between the IgH locus on chromosome 14 and the BCL2 locus on chromosome 18 is the hallmark of follicular lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Histologically, at low magnification, a predominantly nodular or nodular and diffuse growth pattern is observed in involved lymph nodes. Two principal cell types are present in varying proportions: (1) small cells with irregular or cleaved nuclear contours and scant cytoplasm, referred to as <strong>centrocytes (small cleaved cells)</strong>; and (2) larger cells with open nuclear chromatin, several nucleoli, and modest amounts of cytoplasm, referred to <strong>as centroblasts</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Immunophenotyping - The neoplastic cells closely resemble normal germinal center B cells, expressing <strong>CD19, CD20, CD10, surface Ig, and BCL6</strong>. <strong>CD5 is not expressed. BCL2 is expressed in more than 90% of cases.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/16/untitled-399_zKu3XAE.jpg\" alt=\"\" width=\"1000\" height=\"298\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Burkitt Lymphoma:&nbsp;</strong>Typically presents with a high-grade lymphoma and a starry sky pattern on histology. It is associated with c-MYC translocation and does not usually express BCL2.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycosis Fungoides:&nbsp;</strong>A type of cutaneous T-cell lymphoma that presents with skin lesions and does not typically show CD10 or BCL2 positivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic Myeloid Leukemia (CML):&nbsp;</strong>Characterized by the presence of the Philadelphia chromosome (BCR-ABL fusion gene) and presents with marked leukocytosis and often splenomegaly, not with lymphadenopathy and histological findings as described.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Follicular lymphoma is characterized by diffuse effacement of lymph node architecture, cells with indented nuclei and prominent nucleoli, and positive immunophenotyping for CD10 and BCL2. It typically presents in middle-aged individuals with symptoms such as fatigue, tiredness, and lymphadenopathy. The presence of the t(14;18) translocation involving BCL2 is a hallmark of this indolent non-Hodgkin lymphoma.</span></p>",
      "correct_choice_id": 41738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55441,
      "choices": [
        {
          "id": 221225,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GH</span></span></p>"
        },
        {
          "id": 221226,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACTH</span></span></p>"
        },
        {
          "id": 221227,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cortisol</span></span></p>"
        },
        {
          "id": 221228,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following hormone increases during periods of stress, starvation, and deep sleep? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q8705688",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341549,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) GH (Growth Hormone)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Growth Hormone (GH) is known to increase during periods of stress, starvation, and deep sleep. During stress, the body requires more energy, which can be facilitated by the metabolic effects of GH. Similarly, during starvation or hypoglycemia, GH levels rise to help mobilize fat stores and increase blood glucose levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Deep sleep, particularly the NREM stage 3 (previously referred to as stages 3 and 4), is a crucial time for the release of GH. This hormone plays a significant role in growth, cell repair, and metabolism, which are all essential processes that occur during deep sleep.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ACTH:&nbsp;</span></strong><span style=\"font-size:12.0pt\">ACTH (Adrenocorticotropic Hormone) is released in response to stress but not significantly during starvation or deep sleep. Its primary function is to stimulate the production of cortisol from the adrenal glands.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Cortisol:</span></strong><span style=\"font-size:12.0pt\"> Cortisol is another hormone released in response to stress and can be elevated during periods of starvation. However, it does not increase during deep sleep, making it an incorrect answer for this question.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D.</strong> <strong>Prolactin:</strong> Prolactin is not associated with increases during stress or starvation. In fact, stress can decrease prolactin levels, particularly in nursing mothers. Prolactin levels do not significantly increase during deep sleep either.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Growth Hormone (GH) increases during periods of stress, starvation, and deep sleep, especially during the NREM stage 3 of sleep.</span></span></p>",
      "correct_choice_id": 221225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57649,
      "choices": [
        {
          "id": 229965,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an inherited red blood cell disorder causing intravascular hemolysis</span></span></p>"
        },
        {
          "id": 229966,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnosis of the disorder is confirmed by sucrose lysis test</span></span></p>"
        },
        {
          "id": 229967,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the gold standard for diagnosing this condition</span></span></p>"
        },
        {
          "id": 229968,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The commonest cause of mortality is cardiac failure</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a true/correct statement about paroxysmal nocturnal hemoglobinuria? (NEET PG 2024)</span></span></p>",
      "unique_key": "Q1900763",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341551,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.</span></strong><span style=\"font-size:12.0pt\"> <strong>C) Flow cytometry is the gold standard for diagnosing this condition</strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, not inherited, clonal hematopoietic stem cell disorder that leads to red blood cell destruction (intravascular hemolysis), thrombosis, and bone marrow failure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The gold standard for diagnosing PNH is flow cytometry, which detects the absence of GPI-anchored proteins (CD55 and CD59) on red blood cells, granulocytes, and monocytes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;The absence of these proteins makes cells vulnerable to complement-mediated destruction, characteristic of PNH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is an inherited red blood cell disorder causing intravascular hemolysis:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect because PNH is not inherited but acquired due to a somatic mutation in the PIGA gene in hematopoietic stem cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. The diagnosis of the disorder is confirmed by sucrose lysis test:</span></strong><span style=\"font-size:12.0pt\"> The sucrose lysis test is an older screening test for PNH but is not confirmatory. It has largely been replaced by flow cytometry, which is more accurate and specific for detecting the absence of CD55 and CD59.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. The commonest cause of mortality is cardiac failure:</span></strong><span style=\"font-size:12.0pt\"> This statement is incorrect. The most common cause of mortality in PNH is thrombotic complications, especially hepatic vein thrombosis (Budd-Chiari syndrome), not cardiac failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Flow cytometry is the definitive test for diagnosing PNH by demonstrating the absence of CD55 and CD59 on blood cells.</span></span></p>",
      "correct_choice_id": 229967,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 72628,
      "choices": [
        {
          "id": 289501,
          "text": "<p><span style=\"font-size:16px;\">PCT</span></p>"
        },
        {
          "id": 289502,
          "text": "<p><span style=\"font-size:16px;\">Cortical CD</span></p>"
        },
        {
          "id": 289503,
          "text": "<p><span style=\"font-size:16px;\">DCT</span></p>"
        },
        {
          "id": 289504,
          "text": "<p><span style=\"font-size:16px;\">Medullary CD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In Presence of ADH, Maximum osmolarity of tubular fluid will be in which of the following site of nephron? (FMGE JAN 2025)</span></p>",
      "unique_key": "Q5648811",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341444,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Medullary CD</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">ADH increases water permeability in the collecting ducts by inserting aquaporin channels. When ADH is present, as we move from the cortex towards the deep medulla, osmolarity keeps increasing. Though ADH acts on both cortical and medullary collecting ducts, the maximum change in osmolarity occurs in the medullary region due to the countercurrent multiplication system maintaining high osmolarity in the medullary interstitium.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/4444.jpg\" width=\"1248\" height=\"785\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. PCT: Incorrect</strong> because PCT mainly handles obligatory water reabsorption (60-70%) through osmosis, not regulated by ADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Cortical CD: Incorrect</strong> because although ADH acts here, the osmotic gradient in the cortex is much lower than in the medulla.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. DCT: Incorrect</strong> because DCT has minimal water reabsorption (1-3%) without ADH and is not a major site for ADH action.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">While ADH acts on both cortical and medullary collecting ducts, the maximum osmolarity of tubular fluid is achieved in the medullary collecting duct due to the high osmotic gradient maintained by the countercurrent multiplication system in the medulla.</span></p>",
      "correct_choice_id": 289504,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72628/FMGE_Jan_2025_Physiology__Q_-_9.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/72628/FMGE_Jan_2025_Physiology__Q_-_9.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 73120,
      "choices": [
        {
          "id": 291441,
          "text": "<p><span style=\"font-size:16px;\">II CN</span></p>"
        },
        {
          "id": 291442,
          "text": "<p><span style=\"font-size:16px;\">III CN</span></p>"
        },
        {
          "id": 291443,
          "text": "<p><span style=\"font-size:16px;\">V CN</span></p>"
        },
        {
          "id": 291444,
          "text": "<p><span style=\"font-size:16px;\">VII CN</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">In a patient, eye blinking occurs when a doctor touches the eye with a piece of cotton. Which of the following nerves is responsible for carrying sensation? </span><span style=\"font-size:12.0pt;\">(FMGE JAN 2025)</span></p>",
      "unique_key": "Q7049340",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341432,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) V CN (Trigeminal Nerve)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The ophthalmic division (V1) of trigeminal nerve carries sensory information from:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">The cornea and conjunctiva</span></li><li><span style=\"font-size:16px;\">The skin of upper eyelid</span></li><li><span style=\"font-size:16px;\">Forehead and upper face</span><ul><li><span style=\"font-size:16px;\">When cotton touches the cornea, V1 carries this sensory information to the brain&nbsp;</span></li><li><span style=\"font-size:16px;\">This triggers the corneal reflex (protective blinking)</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_njVxXtd.png\" width=\"1145\" height=\"452\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. II CN (Optic Nerve):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This nerve is purely sensory but specifically for vision</span></li><li><span style=\"font-size:16px;\">It carries visual information from the retina to the brain</span></li><li><span style=\"font-size:16px;\">It does not carry touch/tactile sensation from the surface of the eye</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. III CN (Oculomotor Nerve):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is mainly a motor nerve</span></li><li><span style=\"font-size:16px;\">Controls eye movements and pupil constriction</span></li><li><span style=\"font-size:16px;\">Also controls upper eyelid elevation</span></li><li><span style=\"font-size:16px;\">Does not carry sensory information from the eye surface</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. VII CN (Facial Nerve):</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">This is mainly a motor nerve</span></li><li><span style=\"font-size:16px;\">It controls facial muscle movements including eyelid closure</span></li><li><span style=\"font-size:16px;\">While it participates in the blinking reflex by closing the eye (motor part), it does not carry the initial sensory information</span></li><li><span style=\"font-size:16px;\">It is the \"output\" part of the reflex, not the \"input\" sensory part</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The trigeminal nerve (CN V) carries sensory information from the face and eye region, while the facial nerve (CN VII) provides motor innervation for facial expressions including blinking.</span></p>",
      "correct_choice_id": 291443,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8758,
      "choices": [
        {
          "id": 34999,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sodium outflow in thick ascending limb</span></span></span></p>"
        },
        {
          "id": 35000,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Water outflow in thin descending limb</span></span></span></p>"
        },
        {
          "id": 35001,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sodium outflow in thin ascending limb</span></span></span></p>"
        },
        {
          "id": 35002,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flow of tubular fluid from PCT and DCT</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are components responsible for the countercurrent mechanism in the kidney except?&nbsp;(NEET PG 2018)</span></span></p>",
      "unique_key": "Q1681265",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337722,
      "difficulty_level": "difficult",
      "subjects_id": [
        2
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Flow of tubular fluid from PCT and DCT</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PCT and DCT is not a component of the countercurrent mechanism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Countercurrent system has two divisions:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Countercurrent multiplier formed by loop of Henle &amp; Medullary CD</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Countercurrent exchanger formed by vasa recta.</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The major factors that contribute to the buildup of solute concentration into the renal medulla are as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ascending limb of loop of Henle - thick portion (Active transport) and thin portion (Passive transport) of sodium ions and co-transport of potassium, chloride, and other ions into the medullary interstitium</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Descending limb of loop of Henle &ndash; Passive transport of water from the tubules to interstitium</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inner medullary collecting ducts - facilitated diffusion of large amounts of urea into the medullary interstitium</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sodium outflow in thick ascending limb</span></strong><span style=\"font-size:12.0pt\">: Incorrect as exclusion because it is a key component of the countercurrent multiplier, actively transporting sodium out of the tubular fluid.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Water outflow in thin descending limb</span></strong><span style=\"font-size:12.0pt\">: Incorrect as exclusion because it contributes to the countercurrent mechanism by allowing water to passively leave the tubular fluid, increasing its concentration.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Sodium outflow in thin ascending limb</span></strong><span style=\"font-size:12.0pt\">: Incorrect as exclusion; although less active than the thick segment, it still participates in sodium transport.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The flow of tubular fluid from the PCT and DCT is not a component of the kidney&#39;s countercurrent mechanism, which primarily involves the loop of Henle and medullary collecting ducts in actively and passively managing solute and water concentrations to concentrate urine.</span></span></span></p>",
      "correct_choice_id": 35002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11265,
      "choices": [
        {
          "id": 45026,
          "text": "<p><span style=\"font-size:12.0pt;\">Class A</span></p>"
        },
        {
          "id": 45027,
          "text": "<p><span style=\"font-size:12.0pt;\">Class B</span></p>"
        },
        {
          "id": 45028,
          "text": "<p><span style=\"font-size:12.0pt;\">Class C</span></p>"
        },
        {
          "id": 45029,
          "text": "<p><span style=\"font-size:12.0pt;\">Class D</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the Child-Turcotte-Pugh (CTP) class for the patient who has a serum bilirubin 2.5 mg/dl, serum albumin 3 g/dL, prothrombin time 5 seconds (INR = 2), no encephalopathy, and mild ascites?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2020)</span></p>",
      "unique_key": "Q4854419",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Class B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To determine the Child-Turcotte-Pugh (CTP) score, each of the five clinical measures is scored with points from 1 to 3 based on specific criteria:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Bilirubin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">&lt;2 mg/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2-3 mg/dL = 2 points (Patient has 2.5 mg/dL)</span></li><li><span style=\"font-size:12.0pt;\">3 mg/dL = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Albumin:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">3.5 g/dL = 1 point</span></li><li><span style=\"font-size:12.0pt;\">2.8-3.5 g/dL = 2 points</span></li><li><span style=\"font-size:12.0pt;\">&lt;2.8 g/dL = 3 points (Patient has 3 g/dL, scoring 2 points)</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>INR:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">1-1.7 = 1 point</span></li><li><span style=\"font-size:12.0pt;\">1.8-2.3 = 2 points (Patient has INR = 2)</span></li><li><span style=\"font-size:12.0pt;\">2.3 = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Ascites:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point</span></li><li><span style=\"font-size:12.0pt;\">Controlled = 2 points (Patient has mild ascites, scoring 2 points)</span></li><li><span style=\"font-size:12.0pt;\">Refractory = 3 points</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Encephalopathy:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">None = 1 point (Patient has none)</span></li><li><span style=\"font-size:12.0pt;\">Grade 1-2 = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Grade 3-4 = 3 points</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Scoring Calculation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bilirubin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Albumin = 2 points</span></li><li><span style=\"font-size:12.0pt;\">INR = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Ascites = 2 points</span></li><li><span style=\"font-size:12.0pt;\">Encephalopathy = 1 point</span><br><span style=\"font-size:12.0pt;\">Total = 9 points</span></li></ul><p><span style=\"font-size:12.0pt;\">The patient scores 9 points, placing them in Child-Turcotte-Pugh Class B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Child-Turcotte-Pugh scoring system</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/23/screenshot-2024-07-23-185922.jpg\" alt=\"\" width=\"1000\" height=\"462\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Inference:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>CTP A:</strong> 5-6</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP B: </strong>7-9</span></li><li><span style=\"font-size:12.0pt;\"><strong>CTP C: </strong>10-15</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cirrhosis/Chapter 344</strong></span></p>",
      "correct_choice_id": 45027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "CriteriaBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13733,
      "choices": [
        {
          "id": 54893,
          "text": "<p><span style=\"font-size:12.0pt;\">Common hepatic duct</span></p>"
        },
        {
          "id": 54894,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic duct</span></p>"
        },
        {
          "id": 54895,
          "text": "<p><span style=\"font-size:12.0pt;\">Inferior surface of liver</span></p>"
        },
        {
          "id": 54896,
          "text": "<p><span style=\"font-size:12.0pt;\">Gall bladder</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Boundaries of Calot triangle are formed by all except? </span><span style=\"font-size:14px;\">(NEET PG 2019)</span></p>",
      "unique_key": "Q2991776",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341434,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Gall bladder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The gallbladder itself does not form a boundary of Calot's triangle. Instead, it's closely related to the triangle, being situated just adjacent to it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's an important landmark in cholecystectomy (surgical removal of the gallbladder) because of the structures that it contains. The identification of this triangle helps to prevent injury to the common bile duct during surgery.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Boundaries of Calot's triangle is bounded:</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Medially/Left side - Common hepatic duct</strong></span></li><li><span style=\"font-size:12.0pt;\">Right side/ Laterally &nbsp; Cystic duct</span></li><li><span style=\"font-size:12.0pt;\"><strong>Superior - lower surface of liver</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Contents of calot’s triangle - Cystic artery and lymph node of lund&nbsp;</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Common hepatic duct</strong>: This forms the inferior boundary of Calot's triangle. The common hepatic duct is the duct formed by the joining of the left and right hepatic ducts. It later joins the cystic duct to form the common bile duct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Cystic duct: </strong>This duct connects the gallbladder to the common hepatic duct and subsequently forms the common bile duct. The cystic duct forms the lateral boundary of Calot's triangle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cystic artery</strong>: Inferior surface of liver forms the superior boundary of calot’s triangle</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hepatocystic triangle and triangle of Calot - Hepatocystic triangle (blue):</strong> Upper boundary of hepatocystic triangle is the inferior border of liver. Lateral, the cystic duct and the neck of the gallbladder. Medial, the common hepatic duct.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-905.jpg\" alt=\"\" width=\"500\" height=\"336\"></span></p>",
      "correct_choice_id": 54896,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55750,
      "choices": [
        {
          "id": 222433,
          "text": "<p><span style=\"font-size:12.0pt;\">2 years</span></p>"
        },
        {
          "id": 222434,
          "text": "<p><span style=\"font-size:12.0pt;\">6 years</span></p>"
        },
        {
          "id": 222435,
          "text": "<p><span style=\"font-size:12.0pt;\">10 years</span></p>"
        },
        {
          "id": 222436,
          "text": "<p><span style=\"font-size:12.0pt;\">12 years</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Maximum brain growth occurs at which year of life?<strong> </strong>(NEET PG 2024)</span></p>",
      "unique_key": "Q7172294",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337727,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) 2 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brain growth reaches its maximum around 2 years of age. This early and rapid growth phase is crucial for the development of cognitive and motor skills, and it aligns with significant milestones in early childhood development, such as language acquisition, sensory processing, and coordination. The early years are critical for brain development, as synaptic connections are formed at a rapid pace during this time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/02/screenshot-2024-09-02-180355.jpeg\" alt=\"\" width=\"400\" height=\"449\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 6 years:</strong> At 6 years of age, the lymphoid tissues reach their maximum size. The lymphoid system includes the tonsils, adenoids, and other components of the immune system, which are prominent in early childhood to protect against infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 10 years:</strong> This age is not specifically associated with peak growth in any of the major developmental domains mentioned (brain, lymphoid, somatic, or puberty).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 12 years:</strong> This age marks the peak growth for somatic (body) growth and the onset of puberty. During this period, there is a significant increase in height and secondary sexual characteristics as the body undergoes maturation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum brain growth occurs by 2 years of age, emphasizing the importance of early childhood for brain development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Brain Growth max at 2 years</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Lymphoid Growth max at 6 years</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Puberty and Somatic Growth max at 12 years</strong></span></li></ul>",
      "correct_choice_id": 222433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32675,
      "choices": [
        {
          "id": 130550,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 130551,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin D</span></p>"
        },
        {
          "id": 130552,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B3</span></p>"
        },
        {
          "id": 130553,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the vitamin deficiency:&nbsp;(NEET PG 2023)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture23.jpg\" alt=\"\" width=\"300\" height=\"219\"></p>",
      "unique_key": "Q2058536",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337724,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vitamin D</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vitamin D The image show Bowing of the legs, a condition known as bowlegs or genu varum, is commonly associated with Vitamin D deficiency, especially in children. Vitamin D plays a crucial role in the regulation of calcium and phosphorus, essential minerals for bone health. Deficiency of Vitamin D can lead to improper mineralization of bones, resulting in deformities such as bowing of the legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>.&nbsp;<strong>Vitamin A:&nbsp;</strong>Vitamin A deficiency is not typically associated with bowing of the legs. However, severe vitamin A deficiency cause night blindness and other eye menifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vitamin B3 (Niacin):&nbsp;</strong>Vitamin B3 deficiency can cause pellagra, which involves skin, gastrointestinal, and neurological symptoms. It is not directly linked to bowing of the legs.</span></p><p>&nbsp;</p><p><strong>Option D.</strong><span style=\"font-size:14.6667px;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Vitamin B1 (Thiamine):&nbsp;</strong></span><span style=\"font-size:12pt;\">Vitamin B1 deficiency can lead to beriberi, a condition that primarily affects the cardiovascular and nervous systems. It is not a common cause of bowing of the legs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Vitamin D</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-093829.jpg\" alt=\"\" width=\"1000\" height=\"752\"></p>",
      "correct_choice_id": 130551,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83973,
      "choices": [
        {
          "id": 334476,
          "text": "<p><span style=\"font-size:16px;\">Succinyl Choline</span></p>"
        },
        {
          "id": 334477,
          "text": "<p><span style=\"font-size:16px;\">Vecuronium</span></p>"
        },
        {
          "id": 334478,
          "text": "<p><span style=\"font-size:16px;\">Rocuronium</span></p>"
        },
        {
          "id": 334479,
          "text": "<p><span style=\"font-size:16px;\">Cisatracurium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of The following muscle relaxants injection causes maximal pain?<strong>&nbsp;</strong>(NEET PG 2016)</span></p>",
      "unique_key": "Q2290581",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Rocuronium</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Rocuronium is known to cause the <strong>most intense injection pain</strong> among non-depolarizing neuromuscular blockers. The pain is often immediate and described as burning or stinging, largely due to its <strong>low pH&nbsp;</strong>and osmolality, which irritate the vascular endothelium. Pain on injection can occur in <strong>50–80%</strong> of patients when no pretreatment is given. To minimize discomfort, <strong>lidocaine pretreatment</strong> or administration after induction with <strong>propofol</strong> is commonly practiced.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Succinylcholine:</strong> Although succinylcholine may lead to <strong>postoperative myalgia</strong>, it typically <strong>does not cause pain on injection</strong>. Because it is administered rapidly after induction, any injection-related discomfort is rarely noticed.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Vecuronium:</strong> Vecuronium is <strong>virtually painless</strong> on injection. With a near-neutral pH, it is well tolerated and often selected when avoiding injection discomfort is important.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Cisatracurium:</strong> Cisatracurium causes <strong>minimal to no injection pain</strong>. It has a more stable pH and a lower propensity for histamine release compared to atracurium, its parent compound.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Rocuronium causes the most injection pain among neuromuscular blockers, and pretreatment is often needed to reduce discomfort<strong>.</strong></span></p>",
      "correct_choice_id": 334478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6509,
      "choices": [
        {
          "id": 26005,
          "text": "<p><span style=\"font-size:12.0pt;\">Lisinopril</span></p>"
        },
        {
          "id": 26006,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Nifedipine</span></p>"
        },
        {
          "id": 26007,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Atenolol</span></p>"
        },
        {
          "id": 26008,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Clonidine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was started on antihypertensive drugs. Few days later, the patient presented with the following picture. Which of the following drugs is the most likely cause? (NEET PG 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/04/1_SqCWkWZ.jpg\" alt=\"\" width=\"250\" height=\"308\"></span></p>",
      "unique_key": "Q5850259",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337719,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lisinopril</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given picture is suggestive of angioedema. The antihypertensive drug that can lead to the development of angioedema is ACE-Inhibitors – Lisinopril in the given option. Angioedema caused by ACE inhibitors is a class effect, and patients who experience this side effect should not be given any other ACE inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nifedipine</strong>: Nifedipine is a calcium channel blocker used to treat hypertension and angina. It can cause side effects such as headache, flushing, and peripheral edema, but it is not typically associated with angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Atenolol</strong>: Atenolol is a beta-blocker used to treat hypertension and other cardiovascular conditions. Its common side effects include bradycardia, fatigue, and cold extremities, but it does not cause angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Clonidine</strong>: Clonidine is an alpha-2 adrenergic agonist used to treat hypertension. It can cause side effects such as dry mouth, sedation, and rebound hypertension upon abrupt withdrawal, but it is not associated with angioedema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Side effects of ACE-Inhibitors are:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Angioedema</span></li><li><span style=\"font-size:12.0pt;\">Cough</span></li><li><span style=\"font-size:12.0pt;\">Taste disturbances (Dysguesia)</span></li><li><span style=\"font-size:12.0pt;\">Orthostatic hypotension</span></li><li><span style=\"font-size:12.0pt;\">Hyperkalemia</span></li><li><span style=\"font-size:12.0pt;\">They are contraindicated in Pregnancy and in patients with B/L Renal artery stenosis.</span></li></ul>",
      "correct_choice_id": 26005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9973,
      "choices": [
        {
          "id": 39858,
          "text": "<p><span style=\"font-size:12.0pt;\">ATP7A</span></p>"
        },
        {
          "id": 39859,
          "text": "<p><span style=\"font-size:12.0pt;\">ATP7B</span></p>"
        },
        {
          "id": 39860,
          "text": "<p><span style=\"font-size:12.0pt;\">ABCC2</span></p>"
        },
        {
          "id": 39861,
          "text": "<p><span style=\"font-size:12.0pt;\">SERPINA 1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Molecular defect causing liver disease in Dubin-Johnson syndrome is: (NEET PG 2019)</span></p>",
      "unique_key": "Q5774969",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341552,
      "difficulty_level": "beginner",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) ABCC2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Molecular defect causing liver disease in Dubin-Johnson syndrome is ABCC2 (codes for canalicular protein with ATP-binding cassette), it leads to the mutation of multiple drug-resistant protein 2 (MRP2) receptor. Hence, there is a defect in the transfer of conjugated bilirubin from the liver to bile in Dubin-Johnson syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ATP7A:&nbsp;</strong>This gene is associated with Menkes disease, a disorder of copper metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ATP7B:&nbsp;</strong>This gene is associated with Wilson's disease, another disorder of copper metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SERPINA1:&nbsp;</strong>This gene is associated with Alpha-1 antitrypsin deficiency, a condition that can lead to liver and lung disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The molecular defect causing liver disease in Dubin-Johnson syndrome is in the ABCC2 gene, which encodes for a canalicular protein involved in the excretion of conjugated bilirubin.</span></p>",
      "correct_choice_id": 39860,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10103,
      "choices": [
        {
          "id": 40378,
          "text": "<p><span style=\"font-size:12.0pt;\">Two doses of polysaccharide vaccine</span></p>"
        },
        {
          "id": 40379,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibiotic prophylaxis</span></p>"
        },
        {
          "id": 40380,
          "text": "<p><span style=\"font-size:12.0pt;\">Two doses of conjugate vaccine</span></p>"
        },
        {
          "id": 40381,
          "text": "<p><span style=\"font-size:12.0pt;\">Single dose of meningococcal vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Two girls in the same class are diagnosed with meningococcal meningitis. Their 12-year-old friend from the same school is afraid of contracting the disease. What advice should be given to the exposed students? (NEET PG 2020)</span></p>",
      "unique_key": "Q5541590",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341440,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Antibiotic prophylaxis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best advice for the exposed students is to receive antibiotic prophylaxis. This is recommended for close contacts of a person with meningococcal meningitis, such as household members, intimate contacts, and anyone who has had direct contact with the patient's oral secretions. Antibiotic prophylaxis should be initiated as soon as possible after exposure and can be effective in preventing secondary cases of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Two doses of polysaccharide vaccine:&nbsp;</strong>While vaccination is important, it takes time to provide protection. Therefore, it is not the best option for immediate protection in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Two doses of conjugate vaccine:&nbsp;</strong>The conjugate vaccine is recommended for adolescents and children, but similar to the polysaccharide vaccine, it does not provide immediate protection. Antibiotic prophylaxis is still necessary for those who have been exposed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Single dose of meningococcal vaccine:&nbsp;</strong>Again, vaccination alone is not sufficient for immediate protection, and antibiotic prophylaxis is necessary for those who have been exposed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For immediate protection after exposure to meningococcal meningitis, antibiotic prophylaxis is necessary. Vaccination is also recommended but does not provide immediate protection.</span></p>",
      "correct_choice_id": 40379,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 84115,
      "choices": [
        {
          "id": 335040,
          "text": "<p><span style=\"font-size:12.0pt;\">Applanation Tonometry</span></p>"
        },
        {
          "id": 335041,
          "text": "<p><span style=\"font-size:12.0pt;\">Indentation Tonometry</span></p>"
        },
        {
          "id": 335042,
          "text": "<p><span style=\"font-size:12.0pt;\">Dynamic Contour Tonometry</span></p>"
        },
        {
          "id": 335043,
          "text": "<p><span style=\"font-size:12.0pt;\">Rebound Tonometry</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tonometry techniques utilizes the Imbert-Fick Law Principle? (NEET PG 2017)</span></p>",
      "unique_key": "Q1082968",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Applanation Tonometry</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Applanation tonometry is specifically based on the Imbert-Fick Law (P=F/A), where pressure equals force divided by area. This principle states that the pressure inside an ideal sphere equals the force necessary to flatten its surface divided by the area of flattening. In applanation tonometry, the instrument's footplate flattens the cornea, and the pressure required for this flattening directly correlates with intraocular pressure. Fluorescein dye is used during the procedure, viewed under cobalt blue light to identify when the mires juxtapose each other, indicating the measurement endpoint.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Indentation Tonometry:</strong> This method, exemplified by the Schiotz tonometer, works on a different principle where a plunger indents the cornea. It depends on the relationship between the depth of corneal indentation and intraocular pressure, and is affected by scleral rigidity. It does not utilize the Imbert-Fick Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Dynamic Contour Tonometry:</strong> This is a more recent technique using a contoured tip that matches the shape of the cornea to minimize distortion. It uses a pressure sensor to directly measure intraocular pressure rather than applying the Imbert-Fick principle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rebound Tonometry:</strong> This technique involves propelling a small probe toward the cornea and analyzing its rebound characteristics. The deceleration of the probe upon corneal impact correlates with IOP. It works on principles of motion dynamics rather than the Imbert-Fick Law.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Imbert-Fick Law (P=F/A) is the fundamental principle behind applanation tonometry, where the force required to flatten a specific area of cornea directly correlates with intraocular pressure - making it the gold standard for IOP measurement.</span></p>",
      "correct_choice_id": 335040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InstrumentsBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57150,
      "choices": [
        {
          "id": 227989,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CMV</span></span></span></p>"
        },
        {
          "id": 227990,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">EBV</span></span></span></p>"
        },
        {
          "id": 227991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HBV</span></span></span></p>"
        },
        {
          "id": 227992,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient of sickle cell anemia developed aplastic crisis after a viral infection. The agent causing it is: (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q5433403",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337725,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Parvovirus B19</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19 is known for its predilection for erythroid progenitor cells in the bone marrow, which it infects and destroys. This leads to a transient halt in red blood cell production, which can precipitate an aplastic crisis, particularly in patients with underlying hemolytic disorders like sickle cell anemia. The virus effectively shuts down erythropoiesis (red blood cell production), causing a significant drop in hemoglobin levels and resulting in severe anemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Patients with sickle cell anemia are particularly susceptible to this type of crisis because they already have a high rate of red blood cell turnover due to the intrinsic hemolysis caused by their abnormal hemoglobin. When Parvovirus B19 infection superimposes on this condition, the cessation of red cell production can lead to a profound aplastic crisis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. CMV (Cytomegalovirus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CMV is a type of herpesvirus that can cause various infections, especially in immunocompromised individuals, but it is not known to specifically cause aplastic crises or target red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. EBV (Epstein-Barr Virus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> EBV is associated with infectious mononucleosis and can affect the lymphoid tissue but does not directly cause aplastic crisis by targeting red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. HBV (Hepatitis B Virus):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> HBV primarily affects the liver, causing hepatitis, and does not have a known mechanism of inducing aplastic crisis by directly affecting the bone marrow&#39;s red blood cell production.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parvovirus B19 is the primary viral agent responsible for causing aplastic crisis in patients with sickle cell anemia due to its affinity for and destruction of erythroid progenitor cells in the bone marrow.</span></span></span></p>",
      "correct_choice_id": 227992,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 57441,
      "choices": [
        {
          "id": 229137,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></p>"
        },
        {
          "id": 229138,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></p>"
        },
        {
          "id": 229139,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol</span></span></p>"
        },
        {
          "id": 229140,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Streptomycin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with HIV who is currently on antiretroviral therapy consisting of zidovudine, lamivudine, and nevirapine is diagnosed with tuberculosis. Considering potential drug interactions, which of the following TB drugs should be changed in this patient? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q5002348",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337734,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Rifampicin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin is a potent enzyme inducer that significantly increases the metabolism of several drugs, including non-nucleoside reverse transcriptase inhibitors (NNRTIs) like nevirapine. When used together, rifampicin accelerates the metabolism of nevirapine, reducing its efficacy in treating HIV. This interaction can lead to subtherapeutic levels of nevirapine, thereby compromising the effectiveness of the antiretroviral therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with HIV who are on nevirapine-based antiretroviral therapy, rifampicin is usually substituted with rifabutin. Rifabutin has a similar efficacy against tuberculosis but with a lesser degree of enzyme induction, making it a safer option in this context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isoniazid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Isoniazid is generally safe to use in patients on antiretroviral therapy, as it does not significantly interact with most HIV medications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ethambutol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ethambutol does not have significant interactions with antiretroviral drugs and is safe to use in this patient population.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Streptomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Streptomycin, an aminoglycoside antibiotic, also does not interact significantly with antiretroviral therapy and is not the drug that needs to be changed in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For HIV and TB cotreatment:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If a person is on the <strong>TLE regimen</strong> (tenofovir, lamivudine, efavirenz), it does not interact with rifampicin. The regimen can continue unchanged even if rifampicin is given.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the person is on the <strong>TLD regimen</strong> (tenofovir, lamivudine, dolutegravir), the dose of dolutegravir should be doubled when rifampicin is used, while the rest of the regimen remains the same.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the person is taking a <strong>protease inhibitor</strong> or <strong>nevirapine</strong>, rifampicin should be avoided. Instead, rifampicin should be replaced with rifabutin.</span></span></li>\r\n</ul>",
      "correct_choice_id": 229138,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10176,
      "choices": [
        {
          "id": 40670,
          "text": "<p><span style=\"font-size:18px;\">Chi-square test</span></p>"
        },
        {
          "id": 40671,
          "text": "<p><span style=\"font-size:18px;\">Z test</span></p>"
        },
        {
          "id": 40672,
          "text": "<p><span style=\"font-size:18px;\">Unpaired t test</span></p>"
        },
        {
          "id": 40673,
          "text": "<p><span style=\"font-size:18px;\">Paired T test</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>The preferred test for evaluating the difference in means between two study groups, where one group functions as a control, is: </strong><i><strong>[NEET PG 2019]</strong></i></span></p>",
      "unique_key": "Q8231114",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337729,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Unpaired t test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">When comparing the means of two independent groups, where one group serves as a control, the appropriate statistical test to use is the unpaired t-test. This test is designed to determine if there is a significant difference between the means of the two independent groups.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Chi-square test:</strong> This test is used for categorical data to assess whether there is a significant association between two variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Z test:</strong> The Z test is typically used for large sample sizes to compare the means of two populations or to test proportions.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Paired T test:</strong> The paired t-test is used when comparing means from the same group at different times or under different conditions (e.g., before and after treatment).</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-114953.jpg\" alt=\"\" width=\"700\" height=\"376\"></span></p>",
      "correct_choice_id": 40672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of closure of neural tube at week 3 intra-uterine life</span></p>"
        },
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of closure of neural tube at week 4 intra-uterine life</span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of closure of cranial neuropore at week 4 intra-uterine life</span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of closure of caudal neuropore at week 4 intra-uterine life</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following anomaly occurs due to (FMGE JANUARY 2024)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/22/screenshot-2024-06-22-125825.png\" alt=\"\" width=\"300\" height=\"342\"></span></p>",
      "unique_key": "Q7338334",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341547,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Failure of closure of cranial neuropore at week 4 intra-uterine life</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image depicts a condition known as anencephaly, a severe neural tube defect characterized by the absence of a major portion of the brain, skull, and scalp. This condition arises due to the failure of the cranial (anterior) neuropore to close during embryonic development.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Neural Tube Development: The neural tube forms from the neural plate, which folds to create the neural groove and eventually closes to form the neural tube. This process begins around the third week of intrauterine life and continues into the fourth week.</span></li><li><span style=\"font-size:12.0pt;\">Closure of Neuropores: The neural tube has two openings, the cranial (anterior) and caudal (posterior) neuropores. The cranial neuropore normally closes by the 25th day of gestation (around the 4th week), while the caudal neuropore closes by the 28th day (also around the 4th week).</span></li><li><span style=\"font-size:12.0pt;\">Anencephaly: When the cranial neuropore fails to close, the result is anencephaly. This defect prevents the proper formation of the forebrain, resulting in the absence of major portions of the brain and skull.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Failure of closure of neural tube at week 3 intra-uterine life:</strong> This is incorrect because the neural tube begins to close around the third week, but the critical closure of the cranial neuropore occurs in the fourth week.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Failure of closure of neural tube at week 4 intra-uterine life</strong>: This is partially correct but not specific. The specific failure involved in anencephaly is the closure of the cranial neuropore, not just any part of the neural tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Failure of closure of caudal neuropore at week 4 intra-uterine life:</strong> This is incorrect as it refers to the closure of the caudal neuropore, which would lead to defects like spina bifida, not anencephaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anencephaly results from the failure of the cranial (anterior) neuropore to close by the 25th day of gestation, which occurs around the 4th week of intrauterine life.</span></p>",
      "correct_choice_id": 200061,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44004,
      "choices": [
        {
          "id": 175675,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Palm and soles</span></span></span></p>"
        },
        {
          "id": 175676,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Face</span></span></span></p>"
        },
        {
          "id": 175677,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Axilla</span></span></span></p>"
        },
        {
          "id": 175678,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scalp</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Where are the apocrine glands present among the given options? (</span></span></span>INICET Nov 2023)</p>",
      "unique_key": "Q9199854",
      "question_audio": null,
      "question_video": null,
      "map_id": 29337717,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Axilla</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C Axilla</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Apocrine glands are predominantly located in the <strong><em>axillae, areola and groin.</em></strong> </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are sweat glands that become active at <strong><em>puberty</em></strong> and are responsible for the <strong><em>body odor</em></strong> associated with sweating because they produce a <strong><em>thicker, milky</em></strong> sweat that, once degraded by skin bacteria, generates a noticeable odor. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-13-180750.png\" style=\"height:416px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">These glands are most numerous in the axillary region, which is why the axilla is the correct answer.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Palm and Soles</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The skin of <strong><em>palms and soles</em></strong> is primarily populated with <strong><em>eccrine sweat glands</em></strong>, not apocrine. </span></span></span></li>\r\n\t<li value=\"5\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eccrine glands are involved in <strong><em>thermoregulation</em></strong> and are not associated with hair follicles. They produce a <strong><em>watery sweat</em></strong> that is not typically odorous.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Face</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While there are some apocrine glands on the face, they are not as numerous or as active as those in the axilla. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The face primarily contains <strong><em>sebaceous glands</em></strong> and <strong><em>eccrine sweat glands</em></strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Scalp</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The scalp does have apocrine glands, but they are far less concentrated and active compared to those in the axilla. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The scalp also contains eccrine sweat glands and is rich in sebaceous glands.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><em><span style=\"font-size:12.0pt\">Identify the axilla as the primary location of apocrine sweat glands.</span></em></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ref: Rooks textbook of dermatology 9<sup>th</sup> edition Page no 2.8</span></strong></span></span></p>",
      "correct_choice_id": 175677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83690,
      "choices": [
        {
          "id": 333352,
          "text": "<p><span style=\"font-size:12.0pt;\">Appendectomy</span></p>"
        },
        {
          "id": 333353,
          "text": "<p><span style=\"font-size:12.0pt;\">Right Hemicolectomy</span></p>"
        },
        {
          "id": 333354,
          "text": "<p><span style=\"font-size:12.0pt;\">Omentectomy</span></p>"
        },
        {
          "id": 333355,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic wedge resection</span></p>"
        }
      ],
      "text": "<p>What is the treatment of choice for a 0.5 cm carcinoid tumor located at the tip of the appendix? (NEET PG 2016)</p>",
      "unique_key": "Q5785262",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><strong>Correct Answer: A. Appendectomy</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong></p><p>&nbsp;</p><p>For carcinoid tumors of the appendix, the size and location of the tumor are the key determinants for treatment. For tumors less than 2 cm in size that are located at the tip of the appendix, simple appendectomy is considered adequate treatment. Carcinoid tumors of the appendix rarely metastasize, especially when small and distally located. The 0.5 cm tumor described in the question is well below the size threshold that would warrant more extensive surgery.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option B.</strong> <strong>Right Hemicolectomy</strong> - This more extensive procedure is indicated only when: (1) the tumor is 2 cm or larger in size, (2) the base of the appendix or cecal wall is involved, or (3) there is evidence of lymph node metastasis. None of these conditions are present for a 0.5 cm tumor at the tip.</p><p>&nbsp;</p><p><strong>Option C.</strong> <strong>Omentectomy</strong> - This procedure involves removal of the omentum and is not indicated for appendiceal carcinoid tumors unless there is evidence of peritoneal spread, which is extremely rare for small carcinoids.</p><p>&nbsp;</p><p><strong>Option D.</strong> <strong>Hepatic wedge resection</strong> - This would only be considered if there were liver metastases, which are exceptionally rare with small appendiceal carcinoid tumors, especially those &lt;1 cm.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p>Small carcinoid tumors (&lt;2 cm) at the appendiceal tip can be adequately treated with simple appendectomy, as they have minimal metastatic potential and excellent prognosis following this conservative approach.</p>",
      "correct_choice_id": 333352,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5737,
      "choices": [
        {
          "id": 22920,
          "text": "<p><span style=\"font-size:12.0pt;\">Seen within 24 hours of death</span></p>"
        },
        {
          "id": 22921,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to sulphemoglobin accumulation and formation</span></p>"
        },
        {
          "id": 22922,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to aseptic nonbacterial cause</span></p>"
        },
        {
          "id": 22923,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with a case of electrical burns</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the true statement about the image given below? (NEET PG 2021)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/6_i46yAcx.jpg\" alt=\"\" width=\"300\" height=\"202\"></span></p>",
      "unique_key": "Q7381381",
      "question_audio": null,
      "question_video": null,
      "map_id": 29341431,
      "difficulty_level": "beginner",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Due to sulphemoglobin accumulation and formation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The above image shows postmortem change of marbling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Marbling:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Marbling is a characteristic colour change <strong>occurring in Putrefaction </strong>in which the <strong>superficial veins become visible on the skin</strong> due to staining by Hemoglobin or sulphmethhaemoglobin</span></li><li><span style=\"font-size:12.0pt;\">Mechanism of colour change in putrefaction:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>Direct staining by Hemoglobin (Hb):&nbsp;</strong>Lyses of RBCs occur in putrefaction which releases the Hb. This Hb itself stains the tissues and vessels producing a reddish brown coloration which later becomes greenish black.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Staining by Sulph-meth-haemoglobin:&nbsp;</strong>Hydrogen sulphides gas produced by decomposing tissues combine with Hb to form sulph-meth-haemoglobin. This sulph-meth-haemoglobin stains the tissues and vessels producing a greenish black colour.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">This greenish black staining of superficial veins appears as prominent lines on the skin called Marbling</span></li><li><span style=\"font-size:12.0pt;\">Marbling is distinctly appreciable in the superficial veins of abdomen, shoulders, chest and inguinal region.</span></li><li><span style=\"font-size:12.0pt;\">Marbling starts in 24 hours and becomes prominent in about 36–48 hours after death in summer</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seen within 24 hours of death:&nbsp;</strong>While marbling starts within 24 hours, it becomes more prominent at around 36–48 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Due to aseptic nonbacterial cause:&nbsp;</strong>Marbling is a result of bacterial activity and the decomposition process, not aseptic causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is associated with a case of electrical burns:&nbsp;</strong>Marbling is not associated with electrical burns; it is a postmortem change due to putrefaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Marbling, a postmortem change characterized by greenish-black lines on the skin, is due to the accumulation and formation of sulph-meth-hemoglobin during putrefaction.</span></p>",
      "correct_choice_id": 22921,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}